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Blacks are at a higher risk for adverse brain-related outcomes, including stroke and 
dementia. Due to associations of vascular risk factors with brain health, differences in brain health 
may result from a greater burden of vascular risk factors in blacks, especially in midlife. However, 
relationships between vascular risk factors and midlife racial disparities in brain health have been 
underexplored. The overall objective of this dissertation is to improve our understanding of racial 
disparities in brain health outcomes and test for potential mediators of any observed racial 
differences. This objective was addressed through three studies. Since cerebral small vessel disease 
is a major cause of both stroke and dementia, our first study aimed to examine the current literature 
to determine if blacks exhibit more subclinical markers of cerebral small vessel disease than 
whites. We found that blacks appear to be at a greater risk for developing white matter 
hyperintensities, but relationships with other markers of cerebral small vessel disease remain 
unclear. Major limitations in the current literature include: 1) a lack of representation by younger 
age groups, 2) limited geographic representation, 3) few study samples, and 4) the lack of reporting 
diverse markers for brain health. The second study investigated racial differences in brain health 
among a middle-aged population. After adjustment for demographics, blacks exhibited 
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significantly lower gray matter volume, smaller hippocampus, less cortical surface area, and a 
thinner cerebral cortex than whites (p<0.05 for all). No differences in cerebral blood flow were 
found. The third study evaluated whether cardiorespiratory fitness (CRF) and/or cardiometabolic 
risk (CMR) mediate the relationship between race and brain health found in the second study. We 
found that CRF and CMR partially mediated the association of race with cortical surface area and 
gray matter volume. Overall, the findings from these three complementary studies are of public 
health relevance by revealing that brain health disparities exist in an otherwise healthy midlife 
population and by illuminating potential mediators for these disparities. Future work is needed to 
better understand these disparities. Researchers should investigate other potential pathways, 
examine younger populations and observe changes in brain health overtime. 
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This dissertation topic stemmed from observations of epidemiologic trends with regard to racial 
disparities in rates of stroke and subclinical brain disease. It appears that blacks are at greater risk 
of cerebral small vessel disease and brain related sequelae (stroke, dementia, and vascular 
cognitive impairment). If these trends continue unabated, their public health burden will increase 
as the population becomes older and more demographically diverse (Ortman, Velkoff, & Hogan, 
2014; Pantoni, 2010). Current work attempting to identify potential sources of racial health 
disparities in cerebrovascular and brain health are limited. Most of the literature is derived from a 
few samples of limited geographic areas. Also, the majority of studies focus on distal markers of 
disease and include populations older than 65. Problematic from this perspective is that racial 
differences in stroke risk are greatest in populations younger than 65. Each chapter of this 
dissertation contributes to an improved understanding of the epidemiology of racial differences in 
cerebrovascular and brain health. The following introductory sections provide necessary context 
for each dissertation chapter. First, general information about cerebral small vessel disease 
(cSVD), the disease pathology, and documented disparities in brain health are presented. Second, 
we present findings from a review of the literature on racial disparities in subclinical brain health. 
Third, we investigate relationships between race and brain health in a healthy middle-aged 
community sample. Fourth, we will explore potential mediators of relationships between race and 
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brain health. Finally, we will discuss the comprehensive findings of these studies and potential 
directions of future research. 
1.1 CEREBRAL SMALL VESSEL DISEASE  
Small vessels in the brain undergo remodeling and exhibit signs of damage that accumulate with 
older age. Common findings on histopathological examination of postmortem brains of older 
individuals (i.e., those 60 years and older) include tortuosity of venules and arterioles, capillary 
rarefaction, small infarcts, microhemorrhages and enlarged perivascular spaces. These features are 
taken as manifestations of aging microcirculation. With the advent of magnetic resonance imaging 
(MRI), a wider range of cerebral age-related changes have been identified. These include 
parenchymal changes, such as infarcts, lacunes, periventricular spaces and also abnormalities of 
cerebral blood flow (CBF), white matter hyperintensities (WMH) and reduced fiber alignment (via 
diffusion tensor imaging). Although studies relating MRI and histopathological features of age-
related cerebral microcirculation are sparse, the above MRI measures are nonetheless considered 
lesions of presumed vascular origin and are grouped together and referred to as “neuroradiological 
markers of cSVD”(Joanna M. Wardlaw et al.). 
The neuroradiological features of cSVD have become the focus of intense study. Numerous 
reports, reviews and meta-analyses have been published on the relationships between the 
radiological markers of cSVD and negative health outcomes, including stroke, dementia, disability 
and mortality. Although major goals in this field encompass developing a precise understanding 
of cSVD pathogenesis and identifying potential prevention and treatment targets, many pressing 
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barriers to these goals remain unaddressed. Racial differences in markers of cSVD have been 
observed but the reasons behind these disparities remain unknown.  
1.2 RACIAL DISPAIRITIES IN BRAIN HEALTH 
Racial disparities in dementia and stroke are evident (F Gottesman, Fornage, S Knopman, & H 
Mosley, 2015; Husaini et al., 2003; Mozaffarian et al., 2015). Blacks are at a higher risk of stroke 
and developing dementia than whites (G. Howard et al., 2016; Mayeda, Glymour, Quesenberry, & 
Whitmer, 2016). If these trends continue unabated, the public health burden of disparities in 
dementia and stroke will increase as the population becomes older and more ethnically and racially 
diverse (Ortman et al., 2014; Pantoni, 2010). The clearest racial differences in stroke risk are seen 
in those under age 65 (Ayala et al., 2001; Heyman et al., 1971; V. J. Howard, 2013; V. J. Howard 
et al., 2011; Rosamond et al., 1999). Blacks under the age of 65 are estimated to be between 2.2-
4.0 times more likely to suffer from a stroke than whites and twice as likely to die from a stroke 
(Ayala et al., 2001; Heyman et al., 1971; G. Howard et al., 2016; V. J. Howard, 2013; V. J. Howard 
et al., 2011; Rosamond et al., 1999). Additionally, dementia incidence is consistently found to be 
highest among blacks, with modest estimates predicting that blacks are at 40% higher (ranges from 
14% to 100%) dementia risk compared with whites (D. Barnes et al., 2009; Katz et al., 2012; 
Mayeda et al., 2016; Miles, Froehlich, Bogardus, & Inouye, 2001). Finally, vascular dementia 
accounts for a larger proportion of cases in blacks than whites (Mayeda et al., 2016; Miles et al., 
2001). The reasons behind these persistent racial disparities are not fully understood, but it has 
been suggested that there may be differential exposures or susceptibilities to the pathogenic effects 
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of known etiological factors for dementia and stroke among blacks and whites, including cSVD 
(F Gottesman et al., 2015; Gulli et al., 2016; Mayeda et al., 2016; Miles et al., 2001). 
Even prior to the onset of later clinical events and outcomes noted above, blacks appear to 
be at a higher risk for detrimental subclinical brain changes that presage stroke, cognitive 
impairment, and dementia (F Gottesman et al., 2015). For example, studies have found 
associations between black race and reduced cerebral vascular reactivity (Hurr, Kim, Harrison, & 
Brothers, 2015), increased burden of WMH (B Zahodne et al., 2015; Brickman et al., 2008; 
Hannah Gardener et al., 2012; R. F. Gottesman et al., 2010; Nyquist et al., 2014), increased WMH 
progression (F Gottesman et al., 2015; R. F. Gottesman et al., 2010), a higher prevalence of 
subclinical brain infarcts (Bryan et al., 1999; F Gottesman et al., 2015; G. Howard et al., 1998) 
and increased cerebral atrophy (B Zahodne et al., 2015; F Gottesman et al., 2015). Indeed, only a 
few studies have found no racial differences in indicators of brain health (Aggarwal et al., 2010; 
B Zahodne et al., 2015; Bryan et al., 1999; Jennings et al., 2013; Liu et al., 2015), including those 
reporting no racial differences in WMH (Aggarwal et al., 2010; Liu et al., 2015), subclinical brain 
infarcts (B Zahodne et al., 2015; Bryan et al., 1999), and global cerebral blood flow (Jennings et 
al., 2013). However, little is known about racial differences in brain health during midlife., all of 
the above research has been conducted on populations over the age of 65 years. For example, with 
the exception of two of the above studies (Hurr et al., 2015; Jennings et al., 2013), all of the above 
research has been conducted on populations over the age of 65 years.  
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1.3 THE POTENTIAL ROLE OF VASCULAR RISK FACTORS 
Vascular risk factors have been consistently associated with an increased risk of cognitive decline, 
cSVD, and subclinical brain damage (Jorgensen, 2018; Khan, Porteous, Hassan, & Markus, 2007; 
S.-A. Kim & Park, 2015; Qiu & Fratiglioni, 2015; Whitmer, Sidney, Selby, Johnston, & Yaffe, 
2005). The integrity of the vascular system is essential for maintaining proper brain function and 
disturbing the circulatory system of the brain increases susceptibility to damage and degeneration 
(Kalaria, 2010; O’Rourke & Safar, 2005). In the following section we will briefly summarize the 
evidence linking cardiovascular risk factors to brain health and known racial disparities in 
cardiovascular disease.  
In a recent review, we examined potential risk factors for cSVD within healthy aging 
populations (Jorgensen). When examining traditional cardiovascular risk factors, we found that 
association of risk factors with both WMH and SBI/lacunes appears most consistent for 
hypertension and blood pressure parameters. However, descriptive studies examining the 
associations of antihypertensive medications with WMH or SBI/lacunes yield mixed findings. We 
did not find antihypertensive intervention trials in older adults without prior stroke. Measures of 
large vessel disease (stiffness, distensibility, intima media thickness, plaque and heart disease) 
appeared more strongly related to SBI/lacunes than to WMH. This is consistent with a prior 
report(Khan et al., 2007) suggesting different risk profile patterns for WMH as compared to 
SBI/lacunes. However, a recent study of the Lothian Birth Cohort found that a combined vascular 
stiffness score, although being a significant predictor, accounted for less than 2% of the variation 
in the prevalence of WMH (J. M. Wardlaw et al., 2014). This finding is limited in that it was 
conducted in a primarily white sample. Lifestyle factors such as smoking(Debette et al., 2011; 
Dickie et al., 2016; Gons et al., 2011; Knopman, Mosley, Catellier, & Sharrett, 2005; Nyquist et 
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al., 2014; E. J. van Dijk et al., 2008) and sedentary behavior(Sexton et al., 2016) have consistently 
been implicated in higher probability of having WMH and more recently with reduced CVR in 
periventricular white matter.(Gauthier et al., 2015) Among the newer measures of cSVD, Jennings, 
et al. found reduced CBF was associated with increased cardiometabolic risk and worse intima 
media thickness.(Jennings et al., 2013)  
Associations of cSVD with inflammation, dyslipidemia, or obesity were not consistent 
across studies. The state of the evidence is strongest for a positive association of inflammatory 
factors with WMH. Both CRP and IL-6 have been found to be related to WMH, (Nadkarni et al., 
2016); Satizabal, Zhu, Mazoyer, Dufouil, and Tzourio (2012) but overall study results are mixed. 
(Aribisala et al., 2014; Markus et al., 2005; Nadkarni et al., 2016; Satizabal et al.; Schmidt et al., 
1997; Schmidt et al., 2006; E. Van Dijk et al., 2005) Cumulative exposure, longer duration of 
exposure and variability over time in the levels of these factors all appear to be important, but few 
studies examined these characteristics concurrently. We found no strong evidence to support an 
association between inflammatory factors and SBI/lacunes. No studies evaluated inflammatory 
factors in relation to CBF or CVR, and no studies evaluated these associations in those <60 years 
of age. Future studies should focus on those areas and attempt to account for cumulative exposure 
to inflammatory factors.  
Overall, the evidence does not support a strong link between diabetes and cSVD.(Dearborn 
et al., 2015; Debette et al., 2011; G. Howard et al., 1998; Knopman et al., 2005; Knopman et al., 
2011; J. E. Lee et al., 2016; Longstreth et al., 1998; Nyquist et al., 2014; Ramos et al., 2014; 
Schmidt et al., 1997; E. J. van Dijk et al., 2008; Vermeer, Koudstaal, Oudkerk, Hofman, & 
Breteler, 2002) Diabetes may interact with other risk factors such as sleep duration(Ramos et al., 
2014) and SBP,(Knopman et al., 2011) and these interactions should be evaluated in future studies. 
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It has been suggested insulin resistance may be a more sensitive risk factor for SBI/lacunes than 
diabetes, as both cross-sectional (J. E. Lee et al., 2016) and longitudinal associations(Dearborn et 
al., 2015) have been reported.  
Due to the strong associations between vascular risk factors with brain health and function 
(Khan et al., 2007; S.-A. Kim & Park, 2015; Qiu & Fratiglioni, 2015; Whitmer et al., 2005), it is 
possible that racial differences in brain health result from a greater burden of vascular risk factors 
in blacks (F Gottesman et al., 2015; Heyman et al., 1991; V. J. Howard et al., 2011; Mayeda et al., 
2016; Miles et al., 2001; Sacco et al., 2001). However, vascular risk factors have not been fully 
tested as explanatory factors that partly account for racial differences in brain health outcomes (F 
Gottesman et al., 2015). 
Nevertheless, racial differences in cardiovascular health have been documented 
extensively (Havranek et al., 2015). Blacks have been consistently found to have increased 
cardiovascular disease risk and a higher prevalence of cardiovascular disease risk factors, 
including: diabetes, hypertension, physical inactivity, obesity, and smoking (Benjamin et al., 
2017). Additionally, blacks are more likely to have clustering of cardiovascular disease risk factors 
than whites (Sharma, Malarcher, Giles, & Myers, 2003). Blacks have been found to be twice as 
likely as the other racial groups to have 4 or more cardiovascular risk factors and had lowest 
percent of people with no risk factors (Sharma et al., 2003). It appears that there may also be 
differences in the age of onset for many of subclinical cardiovascular disease processes, whereby 
blacks may have earlier onset of hypertension (L. L. Barnes et al., 2016; Heffernan, Jae, Wilund, 
Woods, & Fernhall, 2008; Montagne et al., 2015; Shen et al., 2017) thicker IMT and higher PWV 
at younger ages (Benjamin et al., 2017; Budoff et al., 2006; D'Agostino et al., 1996; T. C. Lee, 
O’Malley, Feuerstein, & Taylor, 2003; Lefferts et al., 2017; Manolio et al., 2008; Orakzai et al., 
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2006; Thurston & Matthews, 2009; Wassel et al., 2009; Wendell, Waldstein, Evans, & Zonderman, 
2017). Blacks in general have been found to have less CAC but increased carotid intima thickness 
than whites and, more recently, that some of these differences may be explained by a genetic 
difference (Benjamin et al., 2017; Budoff et al., 2006; D'Agostino et al., 1996; T. C. Lee et al., 
2003; Manolio et al., 2008; Orakzai et al., 2006; Wassel et al., 2009). Finally, it is important to 
note that SES factors are found to interact with many of these relationships (Thurston & Matthews, 
2009; Wendell et al., 2017).  
Despite evidence the mounting evidence on all sides, studies examining relationships 
between subclinical cardiovascular disease, race, and brain health are rare. How these racial 
differences in the subclinical cardiovascular disease pathology impact brain health is unknown, 
and research in this area could help to elucidate why blacks are at a greater risk of stroke and stroke 
death than other populations(Sharma et al., 2003). 
1.4 CONCEPTUAL MODEL 
The conceptual model reflects much of the preceding thoughts that have driven the hypotheses 
tested within this dissertation. It reflects our understanding of the many potential mediators 
between race and brain health. The model consists of 3 hypothesized relationships between race 
subclinical CVD markers/ mediators and structural brain health. The model also reflects that these 
relationships are not occurring in isolation. Instead we recognize the many possible confounding 
factors including social, demographic, genetic, environmental, health behaviors, and the presence 
of co-morbid conditions. These potential confounding factors are often associated with brain 
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2.1 ABSTRACT 
Background: Blacks are at a higher risk than whites for several adverse brain-related outcomes, 
such as stroke and dementia. Since cerebral small vessel disease (cSVD) is a major cause of both 
stroke and dementia, we aimed to examine whether blacks exhibit more subclinical markers of 
cSVD than whites.  
Methods: We carried out a literature search following PRISMA guidelines to examine the 
estimates of prevalence and risk for markers of cSVD and race in otherwise healthy individuals. 
This review adopts the STRIVE definition of cSVD.  
Results: We found 33 publications which met our search criteria. The average age across 
publications was 65 years, studies samples came from similar geographic locations, a limited 
number of study samples, and most studies examined white matter hyperintensities as a marker of 
subclinical brain health. Blacks appear to be at a greater risk for developing white matter 
hyperintensities. Relationships between race with other markers of brain health remain unclear.  
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Conclusion: Future work needs to be done in younger populations with more geographic variation 
in order to determine whether differences in brain health are due to true differences in risk.  
2.2 INTRODUCTION 
Racial differences in stroke and dementia are evident but the reasons behind these disparities 
remain poorly understood (F Gottesman et al., 2015; Husaini et al., 2003; Mozaffarian et al., 2015). 
If these trends continue unabated, the public health burden of disparities in dementia and stroke 
will increase as the population becomes older and more ethnically and racially diverse (Ortman et 
al., 2014; Pantoni, 2010). Stroke and cerebral small vessel disease (cSVD) share risk factors and 
pathophysiology (J. M. Wardlaw et al., 2014; J. M. Wardlaw, C. Smith, & M. Dichgans, 2013); 
therefore, it would be expected that racial disparities in stroke risk should confer to higher risk for 
subclinical brain changes in blacks before a clinical event (Smith et al., 2017). At the present time, 
advancements in neuroimaging, increased understanding of the underlying neuropathology, and 
changing clinical guidelines and recommendations have begun to shift the focus of research from 
overt stroke events to subclinical brain changes that may be related to stroke pathophysiologically, 
but do not present clinically as stroke (R. Gottesman, Fornage, S Knopman, & H Mosley, 2015; 
Sacco et al., 2013; Joanna M. Wardlaw et al.). These changes present a unique opportunity to 
explore whether racial differences in subclinical brain health are evident in the literature. To this 
date, we are aware of only one review examining racial differences in subclinical brain health and 
it was limited to only ARIC publications(R. Gottesman et al., 2015). In an effort to better 
understand the racial differences in subclinical brain health we completed a review of the literature 
with the focus being on subclinical brain changes. This review will further current understanding 
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of racial disparities in brain health by summarizing findings across several studies, examining 
novel and earlier stage markers of cerebrovascular disease, and by identifying important gaps in 
the current literature.  
2.3 METHODS 
We carried out a literature search to examine the state of research and knowledge surrounding 
markers of cSVD and race in otherwise healthy individuals. This review adopts the STRIVE 
definition of neuroradiological markers of cSVD (Joanna M Wardlaw, Eric E Smith, et al., 2013). 
By this definition, cSVD is thought to comprise a syndrome of radiological manifestations 
affecting brain areas with predominantly poor collateral vascularization (e.g. watershed areas, 
fronto-subcortical regions, etc.). Radiological markers of cSVD include features seen on 
neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities, 
perivascular spaces, and brain atrophy (Joanna M Wardlaw, Eric E Smith, et al., 2013). To account 
for the most recent methodological developments to characterize brain circulation, we include 
more novel markers of cSVD, which appear to be more direct measures of vasculature integrity. 
For example, endothelial dysfunction, an early stage marker of cSVD, can be measured by CBF at 
rest and changes in response to specific challenges (e.g. breath-holding or hypercapnia) (Joanna 
M Wardlaw, Eric E Smith, et al., 2013) We also searched for morphological measures (e.g. 










The search method to examine associations with risk factors is summarized in Figure 1, and it 
follows the PRISMA guidelines (http://www.prisma-statement.org/). We searched PubMed for 
review and original articles examining neuroradiological markers of cSVD (see boxed text for 
definitions). Studies that were cited by the articles thus included were further reviewed and 
included if appropriate. Vessel morphology articles were not found using these search terms, and 
therefore a hand search was carried out. We included studies examining community-dwelling, 
neurologically healthy individuals. Exclusion criteria were: a) hospitalized populations or disease 
state only population without a white comparison group, b) if no race specific estimates were given 
(in text, figures, or supplement), c) narrative reviews. For example, if a study dealt with recent 
stroke patients, that study was excluded. If a study was carried out only in individuals with diabetes 
and no controls, that study was excluded.  
COMMONLY USED NEURORADIOLOGICAL MARKERS OF cSVD 
- White matter hyperintensities: WMH  
- Silent brain infarcts: SBI 
- Lacunes: Small sharply defined regions of tissue loss most frequently 
associated with deep gray and white matter  
- Brain atrophy: A lower brain volume that is not related to a specific 
macroscopic focal injury such as trauma or infarction.  
NOVEL MARKERS OF cSVD  
- Cerebral blood flow (CBF) measured at rest  
- Cerebrovascular reactivity (CVR): changes in CBF after stimulation  
- Morphology of small arteries and veins (e.g. tortuosity, density)   
 
Figure 2.1. Abbreviation 
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2.4 RESULTS 
2.4.1 Characteristics of the Publications  
In this search we identified 293 articles, screened 93 articles, and included 33 studies in this review. 
The mean age across publications was 65.4 years old, with the youngest samples mean age of 23 
years old and the oldest sample mean age of 84.5 years old (Figure 2). The mean age weighted by 
sample size was older by two years at 67.4 years old. One study had a large difference in age 
between the black and white participants, where the average age for the black participants was 
35.6 years and for white participants it was 46.4 years (Isamah et al., 2010). The proportion of 
publications by study in this review can be seen in Figure 3. The two study samples contributing 
the most publications were ARIC at 25% and NOMAS at 16%. We observed geographic trends in 
the sample populations (Figure 4). 31% of the publications were from study populations that the 
black participants were recruited from Jackson, Mississippi and another 28% were from Northern 
Manhattan communities, while all other geographic areas had limited coverage and contributed 
less then 50% to the total. Finally, we found 11 of the 33 articles included in this review had white 
controls from different geographic locations than the blacks (Bryan et al., 1999; Fornage et al., 
2007; R. F. Gottesman et al., 2010; G. Howard et al., 1998; Knopman et al., 2008; Knopman et 
al., 2005; Knopman et al., 2011; Liao et al., 1997; D. Liao et al., 1996; Michos et al., 2014; 
Windham et al., 2017). In GENOA samples whites were recruited from Rochester, MN and blacks 
from Jackson, MS. In ARIC, black participants were primarily recruited from Jackson, MS and 
Forsyth County, NC; while whites were recruited from Minneapolis, MN and Forsyth County, NC. 
However, it is important to note that the proportion of blacks recruited from the Forsyth County, 
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NC site  in the ARIC study is very low at around 12% of the sample from Forsyth County, NC (R. 
Jackson et al., 1996). 
2.4.2 Subclinical markers of brain health 
The associations between races with subclinical measures of brain health is presented in table 1 
and reviewed below.  
2.4.2.1 Small vessel characteristics 
We did not find any studies examining racial differences in small vessel characteristics.  
2.4.2.2 Cerebral Blood Flow 
Three cross-sectional studies examined CBF and found no significant differences in CBF (Hurr et 
al., 2015; Jennings et al., 2013; Selim, Jones, Novak, Zhao, & Novak, 2008). CBF was measured 
using transcranial Doppler in two of the studies (Hurr et al., 2015; Selim et al., 2008) and by 
Arterial Spin Labeled MRI in the other (Jennings et al., 2013). Mean ages for the studies were 23 
(Selim et al., 2008), 43 (Jennings et al., 2013), and 60 (Selim et al., 2008). Two of the studies were 
unadjusted (Hurr et al., 2015; Selim et al., 2008), while one the models controlled for age, current 
smoking status, sex, total brain volume, and Cardiometabolic risk measure or the Framingham 
index (Jennings et al., 2013).  
2.4.2.3 Cerebral Vascular reactivity 
One small study (N=42) among college aged adults (aged 23 +/- 4) found that CVR is lower in 
blacks as compared to age and sex matched whites(Hurr et al., 2015). However, this association 
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was unadjusted for BMI, blood pressure, and other relevant confounders. Although, BMI was not 
significantly different between the two groups, blacks tended to have a higher BMI (p=0.07). 
2.4.2.4 White Matter Hyperintensities  
We found nineteen studies that reported measures of brain health and race, of these three studies 
solely reported interactions and will be discussed at the end of this section. Of the nineteen studies, 
five came from ARIC (R. F. Gottesman et al., 2010; Knopman et al., 2011; Liao et al., 1997; D. 
Liao et al., 1996; Michos et al., 2014), three from NOMAS (Hannah Gardener et al., 2012; J. 
Marcus et al., 2011) (Hudson et al., 2011), two from WHICAP (B Zahodne et al., 2015; Brickman 
et al., 2008), two from Genetic Epidemiology Network of Arteriopathy (Knopman et al., 2008; 
Windham et al., 2017), two are from health ABC samples (Liu et al., 2015; Rosano et al., 2013), 
and the remaining five from other samples. Twelve of sixteen studies found associations with black 
race and WMH (B Zahodne et al., 2015; Brickman et al., 2008; H. Gardener et al., 2012; R. F. 
Gottesman et al., 2010; Knopman et al., 2008; Knopman et al., 2011; Liao et al., 1997; D. Liao et 
al., 1996; Michos et al., 2014; Nyquist et al., 2014; Windham et al., 2017; Yue et al., 1997). Three 
studies found no significant association with black race and WMH (Aggarwal et al., 2010; Liu et 
al., 2015; Prabhakaran et al., 2008; Waldstein et al., 2017), with Liu, Allen et al. 2015 finding the 
relationship with race borderline insignificant (p=0.062), and Waldstien et al. finding no main 
effect but a significant interaction with SES (Waldstein et al., 2017). Three studies examined 
progression of WMH (R. F. Gottesman et al., 2010; Knopman et al., 2011; Michos et al., 2014), 
while most looked at prevalence in cross-sectional analyses (Aggarwal et al., 2010; B Zahodne et 
al., 2015; Brickman et al., 2008; Hannah Gardener et al., 2012; Knopman et al., 2008; Liao et al., 
1997; D. Liao et al., 1996; Liu et al., 2015; Nyquist et al., 2014; Prabhakaran et al., 2008; Waldstein 
et al., 2017; Windham et al., 2017; Yue et al., 1997),  and only two examined the relationships in 
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those under age 60 (Nyquist et al., 2014) (Waldstein et al., 2017). The findings from the three 
longitudinal papers are particularly interesting as it they were the only studies which examined 
progression of WMH, all finding that substantial progression of WMH occurred in blacks over the 
roughly 10-year period, compared to whites.  
Few studies reported potential risk factor interactions with race(J. Marcus et al., 2011; 
Waldstein et al., 2017). After stratifying by quartiles of DBP, Marcus et al. found blacks had more 
WMH than whites only if their DBP was above the lowest quartile of DBP, suggesting an 
interaction with DBP(J. Marcus et al., 2011). Waldstein et al. found a significant interaction 
between a measure of SES and WMH, where blacks with low SES has significantly greater lesion 
volume than whites, but there was no racial differences among high SES groups(Waldstein et al., 
2017). Furthermore, these studies varied in how potential confounders were adjusted for three were 
unadjusted (Aggarwal et al., 2010; B Zahodne et al., 2015; H. Gardener et al., 2012) and two were 
minimally adjusted (age and sex)(Brickman et al., 2008; J. Marcus et al., 2011). 
The two studies that did not find any significant associations (Aggarwal et al., 2010; Liu 
et al., 2015) were both cross-sectional studies in populations with mean ages ~80 years old and 
above, however, the null findings cannot be due to age alone as (B Zahodne et al., 2015; Brickman 
et al., 2008) also in populations over 80. The overall prevalence of hypertension in the Liu et al. 
study was very high in both whites and blacks (80% and 86% respectively (p=0.20)) which is 
unusual given that blacks tend to have a higher prevalence of hypertension, and other studies have 
observed this even in older age groups (B Zahodne et al., 2015; Brickman et al., 2008) suggesting 
that the comparison population may have been sicker than participants in other studies. Thus, 
diminishing the difference in WMH between the two groups. Estimates from the Aggarwal et al. 
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publication were unadjusted and did not report prevalence of CVD risk factors, making it difficult 
to identify what study population characteristics may have contributed to this difference.  
2.4.2.5 SBI / Lacunes 
Six of seven the studies examining SBI and race were cross-sectional analysis (Aggarwal et al., 
2010; B Zahodne et al., 2015; Bryan et al., 1999; Bryan et al., 1997; G. Howard et al., 1998; 
Prabhakaran et al., 2008; Yue et al., 1997) one was longitudinal (Knopman et al., 2011). Two 
studies found an association between SBI/lacunes and black race (Bryan et al., 1999; G. Howard 
et al., 1998; Prabhakaran et al., 2008) and both happen to be from ARIC samples. Four studies 
found no significant associations (Aggarwal et al., 2010; B Zahodne et al., 2015; Bryan et al., 
1997; Prabhakaran et al., 2008; Yue et al., 1997). However, the estimates from three of these 
studies (B Zahodne et al., 2015; Bryan et al., 1999; Bryan et al., 1997; Yue et al., 1997) were 
unadjusted and therefore these findings could be confounded by differences in the populations. 
The Prabhakaran et al. and Howard et al. studies made appropriate adjustment for covariates and 
came up with seemingly different results. Prabhakan et al. initially found differences in prevalence 
of SBI among different racial groups, but after adjustment these were attenuated and became non-
significant. Notably, Prabhakaran et al. found a significant interaction between race and age, where 
younger blacks had the highest odds of SBI. This could potentially explain the difference in 
findings, given the younger age distribution of the Howard et al. sample population. It could be 
that the difference in SBI is only seen at younger ages and may disappear with age either due to 
survival bias or other factors. Hudson et al. only reported findings of an interaction with where 
higher levels of soluble Receptor for Advanced Glycation End-products were protective against 
SBI (Hudson et al., 2011). 
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2.4.2.6 Atrophy / Total Brain Volume 
We found ten cross-sectional studies originating from 9 samples that evaluated brain atrophy or 
examined brain volumes(Aggarwal et al., 2010; B Zahodne et al., 2015; Brickman et al., 2008; 
Fornage et al., 2007; Knopman et al., 2008; Knopman et al., 2005; Liu et al., 2015; Longstreth Jr 
et al., 2000; Prabhakaran et al., 2008; Waldstein et al., 2017; Yue et al., 1997) and one longitudinal 
study (Knopman et al., 2011).  Of these studies, three found more brain atrophy or reduced total 
brain volume in blacks compared to whites (Fornage et al., 2007; Knopman et al., 2008; Waldstein 
et al., 2017), four found no difference (Aggarwal et al., 2010; Knopman et al., 2005; Liu et al., 
2015; Prabhakaran et al., 2008; Yue et al., 1997), and two found greater total brain volume in 
blacks compared to whites (Brickman et al., 2008; Longstreth Jr et al., 2000).  
2.4.2.7 Hippocampal Volume 
Four studies reported hippocampal volumes, two found reduced hippocampal size among blacks 
(Isamah et al., 2010; Prabhakaran et al., 2008), one found no difference (Brickman et al., 2008) 
and one found greater hippocampal size compared to whites (B Zahodne et al., 2015). Both the 
study finding no difference and the other finding a larger hippocampal size in blacks came from 
the WHICAP sample. Only one of the studies was in a sample less than 60 years old (Isamah et 
al., 2010). Although, Zahodne et. al reported somewhat contradictory findings, where black 
participants had greater hippocampal than whites but reduced cortical thickness (B Zahodne et al., 
2015).  
2.4.2.8 Ventricular Size 
Seven studies reported ventricular size (Brickman et al., 2008; Isamah et al., 2010; Knopman et 
al., 2008; Knopman et al., 2005; Knopman et al., 2011; Longstreth Jr et al., 2000; Yue et al., 1997). 
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Three found no difference in ventricular size (Isamah et al., 2010; Knopman et al., 2005; Knopman 
et al., 2011) and four found better ventricular size (Brickman et al., 2008; Knopman et al., 2008; 
Longstreth Jr et al., 2000; Yue et al., 1997). The Knopman et al. paper reported that while there 
were no differences in ventricle size at baseline, black males had significantly higher ventricular 
worsening compared to white males (Knopman et al., 2011); there were no significant racial 
differences between females. 
2.4.2.9 Sulcal Size 
Four studies reported differences in sulcal size (Knopman et al., 2005; Knopman et al., 2011; 
Longstreth Jr et al., 2000; Yue et al., 1997). One reported no difference (Knopman et al., 2005) 
and two reported better sulcal grades among blacks (Longstreth Jr et al., 2000; Yue et al., 1997). 
In a longitudinal analysis Knopman et al. found worse sulcal grades among black males compared 
to white males but no racial differences among females, conversely at follow-up fewer blacks than 
whites and sulci grade worsening (Knopman et al., 2011).  
Only two of these studies reported interactions with race (Brickman et al., 2008; Waldstein 
et al., 2017). Brickman et al. found that vascular disease was associated with smaller relative brain 
volume, particularly among blacks (Brickman et al., 2008). Waldstein et al. found significant 
interactions with SES and race for all outcomes (Waldstein et al., 2017). 
2.5 DISCUSSION 
In summary, few prospective studies have examined the relationships between race and the 
development of cSVD markers. Most of the research has focused on cross-sectional examinations 
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(prevalence or odds ratios) without examining if race impacts the risk of development of this 
disease pathology. The Knopman et al. and Gottesman et al. papers were the only two found to 
examine progression of subclinical disease markers and both were from ARIC study samples (R. 
F. Gottesman et al., 2010; Knopman et al., 2011). Gottesman et al. found that blacks were more 
likely to have significant WMH disease progression(R. F. Gottesman et al., 2010). Knopman et al. 
found that while significantly more blacks had SBI at baseline when compared to whites, there 
was no difference in the rate of progression between races (Knopman et al., 2011). The vast 
majority of the evidence examines WMH, SBI, and total brain volumes, with only a few studies 
looking at CBF and one examining CVR.  
The mean age across publications included in this review is 65.4 years old. Given that 
blacks are known to have a higher risk of stroke and stroke death, particularly under the age of 65 
years, the findings from studies in older populations may be subject to survival bias. Where the 
blacks participating in these MRI studies may be particularly resilient and the true population 
differences in brain health may be underestimated. Given there is such a disparity in stroke risk by 
age, it is imperative that future work examines younger populations, earlier markers, and uses 
advanced statistical methods to account for survival bias.  
 Over 50% of studies are derivative from black populations in Jackson, MS and northern 
Manhattan communities which is problematic given that there are documented geographic trends 
in stroke risk, whereby in regions known as the “stroke-belt” the risk of stroke and exposure to 
risk factors is much higher (Borhani, 1965). Additionally, it has been previously found that the 
stroke mortality ratio, comparing blacks to whites, varies among states (G. Howard, Howard, 
Katholi, Oli, & Huston, 2001). For example, it was found that blacks in Florida have 92% higher 
risk of dying from stroke than whites, while blacks in New York are only at a 6% higher risk (G. 
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Howard et al., 2001). In a further analysis, Howard et al. found that the age adjusted black-to-
white stroke mortality ratio was consistently higher for southern states compared to non-southern 
states and that this difference is larger than what is expected from accounting for the increased 
risk in the “Stroke Belt” (V. J. Howard, 2007). Therefore, the studies sampling southern blacks 
and northern whites, (Bryan et al., 1999; Fornage et al., 2007; R. F. Gottesman et al., 2010; G. 
Howard et al., 1998; Knopman et al., 2008; Knopman et al., 2005; Knopman et al., 2011; Liao et 
al., 1997; D. Liao et al., 1996; Michos et al., 2014; Windham et al., 2017) may see differences in 
risk that are due to geography alone, but since they are unable to properly adjust for geographic 
confounds, it may be difficult to determine whether the racial differences in brain health are due 
to geography or other factors.  
 Overwhelmingly, most studies reported measures of WMH and most of these studies 
found a relationship between increased WMH in blacks as compared to whites (B Zahodne et al., 
2015; Brickman et al., 2008; Hannah Gardener et al., 2012; R. F. Gottesman et al., 2010; 
Knopman et al., 2008; Knopman et al., 2011; Liao et al., 1997; Duanping Liao et al., 1996; 
Michos et al., 2014; Nyquist et al., 2014; Windham et al., 2017; Yue et al., 1997). Evidence was 
unclear for SBI, atrophy, hippocampal volumes, and sucal grades. The evidence above appears to 
suggest that there is no difference in CBF between blacks and whites and no difference or 
potentially better ventricular grades among blacks. These unexpected findings could be the result 
of survivor bias, as the ages of subjects in these studies are over 65 and may potentially reflect 
mechanisms of resilience. There were no studies reporting racial differences in small vessel 
characteristics and only one study reporting impaired CVR among blacks. Future work should be 
done to assess novel markers of cSVD including CVR and small vessel characteristics in 
younger populations to reduce survival bias.  
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 It has been theorized that such seemingly premature appearance of cSVD among blacks 
could be due to the higher burden of cardiovascular risk factors and diseases in blacks as compared 
to whites. However, substantial evidence in support of this theory is lacking. Only two publications 
included in this review had comprehensive measures of vascular-related characteristics.(R. F. 
Gottesman et al., 2010; Prabhakaran et al., 2008) Furthermore, the role of cardiovascular risk 
factors remains unclear as the findings of these two publications came to somewhat opposing 
conclusions. One found that adjustment for cardiovascular risk factors (smoking, hypertension, 
diabetes, hypercholesterolemia, and cardiac disease)(Prabhakaran et al., 2008) attenuated racial 
differences, whereas the other did not (R. Gottesman et al., 2015; R. F. Gottesman et al., 2010). It 
is important to note that time of exposure and of measurement of the outcomes, as well as duration 
of exposure all need to be taken into account. We noticed that cardiovascular risk factors were 
often measured at an older age in studies where cardiovascular risk factors failed attenuate racial 
differences in cSVD.(R. F. Gottesman et al., 2010; Nyquist et al., 2014) Perhaps the explanatory 
effect of cardiovascular risk factors is stronger earlier in age, as compared to later in life, when the 
process of cSVD accumulation has already been unfolding for a long time. Another possibility is 
that the older subgroups of blacks who are participating in MRI studies are exceptionally resilient. 
Blacks are known to have a higher risk of death and morbidity as compared to whites; hence, 
studies with older subgroups of blacks may be vulnerable to survival bias.  
In summary, more work needs to be done in order to determine the reasons underlying 
racial health disparities in stroke and dementia risk. In order to reduce confounding that may be 
due to geography, future studies to include multiple geographic sites and ensure both white and 
black participants are recruited from each site. Also, we would suggest that future studies should 
begin to focus on younger age groups, without clinical disease, and early stage markers of the 
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disease process. Expansion of this research is key in resolving these health disparities by 
determining risk factors and developing a clearer understanding of the underlying pathologic 
mechanisms prevention or delay of stroke and dementia is possible.  
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2.6 TABLES AND FIGURES 
 
Figure 2.2 PRISMA guideline summary of articles included in review 
Adapted from:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. 






Figure 2.3 Distribution of mean ages across publications 
 
 
Figure 2.4 Neuroimaging measurement by publication 
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Brain health Positive  Negative No Significant Differences 
CBF     Selim et al., 2008; Jennings et al., 2013; Hurr et al., 2015 
CVR   Hurr et al., 2015    
WMH 
Liao et al., 1996; Liao et 
al., 1997; Yue et al., 
1997;  Brickman et al., 
2008;  Knopman et al., 
2008; Gottesman et al., 
2010; Knopman et al., 
2011; Gardener et al., 
2012; Michos et al., 
2014; Nyquist et al., 
2014; B Zahodne et al., 
2015; Windham et al., 
2017 
  
Prabhakaran et al., 2008; 
Aggarwal et al., 2010; Liu et 
al., 2015; Waldstein et al., 
2017 
SBI Howard et al., 1998; Bryan et al., 1999   
Bryan et al., 1997; 
Prabhakaran et al., 2008; 
Aggarwal et al., 2010; B 
Zahodne et al., 2015 
Atrophy  
Fornage et al., 2007; 
Knopman et al., 2008; 
Waldstein et al., 2017 
Longstreth et al. 
2000; Brickman 
et al., 2008 
Knopman et al., 2005; 
Prabhakaran et al., 2008;  
Aggarwal et al., 2010; Liu et 
al., 2015 
Hippocampal 
volumes B Zahodne et al., 2015 




Brickman et al., 2008 
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Ventricular 
Size   
Yue et al., 1997; 
Longstreth et 
al., 2000; 
Brickman et al., 
2008; Knopman 
et al., 2008 
 Knopman et al., 2005; Isamah 
et al., 2010; Knopman et al., 
2011 
Sulcal Grade Knopman et al., 2011 
Yue et al., 1997; 
Longstreth et 
al., 2000 
Knopman et al., 2005 
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Covariates Major results 
regarding race 
(Duanping 








aged 62; 62% 
female; 49% 
black 
WMH Race, htn, blood 
pressure 
age, ethnicity and sex 1. Blacks with htn had 
↑ odds of having 
WMH grade >3 
compared to whites.  
2. Adjustment for 
SBP and DBP 
attenuated the 
relationship but it 
remained significant. 





Health Study; N= 
3658; aged 72.2; 
58% female; 
15.36% black 
SBI Age. Sex, race unadjusted 1. SBI prevalence was 
not differ between 
blacks and non- 
blacks. 








aged 62; 62% 
female; 49% 
black 
WMH hypertension, blood 
pressure, race 
age, ethnicity and sex 1. Blacks had ↓ 
prevalence in WMH 
overall. 
2. Blacks had a ↑ 
prevalence of severe 
WMH (>= grade 3) 
than in whites.  
3. Associations 
between risk factors 
for the development 
of WMH in the study 
(smoking, alcohol 





hypertension were all 
stronger for the AAs 
than for the whites 
(p<0.15 for the 
interaction). 







>65 yrs; % 
female not given. 
15% black 
 













age, sex, and race. 
 
age, sex, and race 
 
1. Black race was ↔ 
with: 
↑ White matter grade, 
↓ ventricular and ↓ 
sulcal grades 
 
2. Healthy subgroup: 
race was n/s with 
ventricular or sulcal 
grade.  
 








aged 63; 62% 
female; 48% 
black 
SBI/Lacunes smoking, race smoking, age, race, 
sex, htn, diabetes, 
HDL, TG, alcohol 
use, BMI, leisure-
time activity, dietary 
fat intake (indexed as 
a Keys score) 
1. black race ↔ ↑ SBI  
 







Study; N= 1890; 
SBI/Lacunes race unadjusted 1. black race↔↑SBI 
prevalence  
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and sulcal grade 
Age, race, sex Sex stratified:  
male models 
controlled for: Age, 
years of school, CHF, 
pack years of 
smoking, alcohol, 
insulin use, abnormal 
electrocardiogram, 
IMT, white matter 
grade. Female models 
controlled for age,  
smoking, diabetic 
medication, estrogen 
use, albumin, and 
white matter grade.  
Black race was ↔ 
with: 
1. ↓ ventricular grade 
2. ↓ sulcal grade 








Study; N= 1812; 





and sulcal size 
CVD risk factors age, race, and sex Race n/s ↔  with 
ventricular size or 
sulci size scores after 
age and sex 
adjustments 
 (Fornage et 








756; blacks aged 
64 yrs and whites 
aged 62 yrs; 
WMHV, total 
brain volume 
variation in the 
genes encoding 
MMP3 and MMP9 
 
unadjusted Black race was ↔ 
with: 
1. ↑WMH volume 
(2.2 cm3 diff)  
2. ↓brain volume 
(86.5 cm3 diff) 


















N= 769; aged 













score range, 0-4 1 
point for each: 
diabetes, htn, heart 
disease, and clinical 
stroke) 
age, sex 1. black race ↔↑more 
severe WMH burden 
2. associations with 
age were similar 
across racial-ethnic 
groups.  
3. vascular disease ↔ 
↑WMH burden, 
particularly in blacks  
4. no sig diff in 
hippocampal volume 
or entorhinal cortex 
volume 
5. black race ↔↑total 
brain volume 
6. black race ↔ ↓ 
ventricles 
7. interaction: black 











N= 184 controls; 
aged 73.5 yrs; 
Brain volume, 
hippocampal 
volume, log of 
WMH 
Race and cognitive 
status 
age, gender, 
education, racial or 
ethnic status 
Blacks had a ↓ 
hippocampal volume, 
but no p-value 
reported comparing to 
white.  
 




Main effect of race 
and TBV appears to 
be driven by 
Hispanics not blacks.  
 



















(calculated by total 
intracranial 








ratio, race and sex 
age at time of MR 
exam, gender, race, 
and total intracranial 
volume (for BA and 
VV) or brain volume 
(for WMH) 
 
Black race was ↔ 
with: 
 
1. ↑ brain atrophy  
 
2. ↓ ventricular 
volume  
 
3. ↑ WMH volume 
  
(Prabhakaran 





Study; N= 892; 
aged 71.3; 59.0% 
female; 19.2% 
black 







1. Black race (ns after 
adjustment) ↔ ↑SBI 
2. Significant 
interaction of race and 
age such that younger 
blacks had ↑odds of 
having SBI. 







6% of controls 
black;  
CBF – measured 
by transcranial 
dopplar  
cerebral blood flow 
regulation in 
patients with type-2 
diabetes mellitus, 
hypertension, and 





Flow velocities in the 
middle cerebral 
arteries were reduced 
in blacks but this was 
not significant. 









N= 575; aged 







race unadjusted Black race was: 
1. n/s ↔ with WMHV 
2. n/s ↔ infarcts 
3. n/s ↔ having >1 
infarct  
4. n/s ↔ with WMHV 



























SBP 5 times (1st 4 
visits ~3 yrs apart 
and 5th visit about 7 
yrs after 4th visit) 
age, sex, education, 
prevalent CHD at 
visit 3, diabetes at 
visit 3, BMI at visit 3, 
race, smoking status 
at visit 3 
1. black race 
↔substantial WMH 
progression 
2. no significant 
interaction with 20 
mm-hg increase in 
cumulative mean SBP 
by race 





aged 46.4 yrs, 






cortex, the caudate 




  age, sex, total 
cerebral volume and 
education level in 
years as independent 
variables. 
 
Black race was ↔ 
with:  
1. ↓ total brain 
volume  
2. ↑ left/ right 
orbitofrontal cortex 
volumes 
3. ↓ Right amygdala 
3. ↓ Left amygdala 
but n/s (p=0.06) 
 
4. n/s differences in 
total white matter, 
total gray matter, 
left/right Caudate, or 
ventricular volumes.   























HDL, LDL, diabetes, 
Estimated Glomerular 
Filtration Rate, 






sRAGE levels and 
MRI measurements 
Among blacks, those 
in the upper quartile 
of sRAGE had a 
similarly ↓ risk of SBI 




















Diabetes unadjusted At baseline Black race 
was ↔ with: 
1. ↑ sulci grade in 
males 
2. n/s sulci grade in 
females 
3. n/s ventricular 
grade 
4. ↑ WMH grade 
 progression of WMH 
of >=1 grade 




1. ↑ ventricular 
worsening in black 
men 
2. n/s in females 
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3. ↓ sulci grade 
worsening 
4. ↑ WMH grade 
 progression of WMH 
of >=1 grade 
5. n/s incident infarcts  
 (Justin 










Study; N= 1,281; 
aged 64 yrs; 
59.3% female; 
64.6% Hispanic, 




Measured at the 
end of follow-up 
Blood pressure Race, TCV 1. Blacks with DBP in 
Q2, Q3, or Q4 had 
↑WMH than whites of 
the same quartile of 
BP. 
 
2. n/s difference 
between whites and 
blacks in Q1 of DBP.  
 
3. ↔ b/t DBP and 













Study; N= 966; 
aged 72 yrs; 60% 
female; 66% 
Hispanic, 15% 




Measured at the 









to heavy physical 
activity, caloric 
intake, smoking, 
LDL, HDL, SBP, 
DBP, interaction 
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diabetes, cardiac 
disease hx, BMI  




 10 yrs 
follow-up   
Healthy Brain 
Project; N=303; 





measured at end of 












slope of change in 
SBP, DBP, PP, and 
BMI 
 
1. ↑ PWV ↔ with  ↑ 
WMHV roughly 10 












42.6 yrs; 53% 
female; 83% 
white 
CBF  vascular risk factors age, race, current 
smoking status, sex, 
total brain volume, 
cardiometabolic risk 
measure, MetS, or the 
Framingham Index 
1. ↑ cardiometabolic 
risk indices ↔ ↓ CBF 
2. ↑Framingham risk 
and ↑ cIMT↔↓CBF 
3. ns: race with CBF 













Vitamin D Unadjusted  In those with 
clinically normal 
vitamin D, black race 
was ↔ with: 
 
1. ↑ prevalence of 
white matter score>3  
2. ↑ white matter 
progression 












race and other 
known vascular risk 
factors 
age, sex, htn, 
diabetes, current 
smoking, obesity 
Black race was ↔ 
with: 
1. extreme WMH 
CHS scores 
2. extreme DWMHV 
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index case; aged 
51.5 yrs; 58.3% 
female;36% 
black 
3. in race-stratified 
analysis: ↑age and 
female sex ↔extreme 
DWMH in blacks; 
↑age and obesity 
















CMB  Unadjusted No racial differences 
in prevalence or 
location of CMB. 




N=42; aged 23; 
52% female; 
50% black 




Race unadjusted Blacks race was ↔ 
with:  1. attenuated 
cerebral vascular 
capacity to respond to 
hypercapnia  
2. n/s diff in resting 
CBF 

















race unadjusted Black race ↔ with: 
1. ↑ WMHV 
2. ↓ Cortical thickness 
3. ↑ Hippocampal 
volume 
4. ns: race with SBI  
 












aged 83 yrs; 
42.0% female; 
40.6% black 
WMH, MD, Grey 
matter atrophy 
race sex, income, literacy, 
BMI, diabetes and 
drinking habits 
1. Black race was ↔ 
with  
↓  mean diffusivity 
(e.g. ↑ gray matter 
micro-structural 
integrity, p=0.032), 
independent of sex, 
income, literacy, body 
mass index, diabetes 
and drinking habits.  
2. Racial differences 
were not significant 
for WMH or Grey 
matter atrophy. 





aged 70 yrs; xx% 
female; 15% 
black 
CMB race age, cerebral 
parenchymal fraction, 






The difference in 
CMB distribution was 
not statistically 
significant across 






Healthy Aging in 
Neighborhoods 
of Diversity 
across the Life 
Span; N=147, 





volume, total brain 
volume, grey 
matter volume, 
and white matter 
volume  
 
Race, SES Age, sex, SES Black race was ↔ 
with: 
1. ↓ TBV (B=−83.95 
cc, p<.001),  
2. ↓ grey matter 
volume (B=−47.47cc, 
p<.001) 
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4. ns: race with 
WMHv 
  
5. significant race x 
SES interactions for 






















age, sex, diabetes, 




smoking, high density 
lipoprotein 
cholesterol, and total 
intracranial volume. 
Models for WC 
included height. 
 
Black race was ↔ 
with: 
 
1. ↑ WMHv  
2. more variable 
WMH 3. n/s: atrophy 
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 RACIAL DIFFERENCES IN BRAIN HEALTH AT MIDLIFE 
Dana R. Jorgensen, MPH Department of Epidemiology, University of Pittsburgh Graduate 
School of Public Health, Pittsburgh, PA, USA; Dora C. Kuan Department of Psychology, 
University of Pittsburgh, Pittsburgh, PA, USA; Akira Sekikawa, MD PhD PhD, Department of 
Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. 
Peter J. Gianaros, PhD, Department of Psychology, University of Pittsburgh, Pittsburgh, PA, 
USA. 
3.1 ABSTRACT 
Background: Blacks are at a higher risk than whites for several adverse brain-related outcomes, 
such as stroke and dementia. Further, much of what is known about racial differences in brain 
health is nearly exclusive to those >65 years old. It thus remains unclear whether relationships 
between race and brain health are apparent in midlife. 
Methods: 747 community volunteers (20.6% black) aged 30–54 years old, underwent 
neuroimaging to assess brain morphology and cerebral blood flow (CBF). Linear regression was 
used to examine relationships between race and brain health after controlling for potential 
differences in demographic factors (age, sex, years of schooling, family income, and current 
smoking).  
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Results: After adjustment for demographics, blacks exhibited significantly lower gray matter 
volume, smaller hippocampus, less cortical surface area, and a thinner cerebral cortex than whites 
(all p’s<0.05). We observed no significant differences in CBF by race. Similar but attenuated 
effects were seen in sex stratified models. There remained a significant and unexplained effect of 
race on hippocampal volume, cortical surface area, mean cortical thickness, cortex volume, and 
gray matter volume equivalent to: 29.04, 9.47, 10.66, 9.20 and 13.96 years of aging, respectively. 
Conclusion: Race differences in brain health are evident in midlife. These results have 
implications for understanding the pathways by which race may impact brain health prior to the 
onset of stroke and other clinical outcomes later in life. 
3.2 INTRODUCTION 
Racial disparities in dementia and stroke are evident (F Gottesman et al., 2015; Husaini et al., 
2003; Mozaffarian et al., 2015). Blacks are at a higher risk of stroke and developing dementia than 
whites (G. Howard et al., 2016; Mayeda et al., 2016 & Whitmer, 2016). If these trends continue 
unabated, the public health burden of disparities in dementia and stroke will increase as the 
population becomes older and more ethnically and racially diverse (Ortman et al., 2014; Pantoni, 
2010). The clearest racial differences in stroke risk are seen in those under age 65 (Ayala et al., 
2001; Heyman et al., 1971; V. J. Howard, 2013; V. J. Howard et al., 2011; Rosamond et al., 1999). 
Blacks under the age of 65 are estimated to be between 2.2-4.0 times more likely to suffer from a 
stroke than whites and twice as likely to die from a stroke (Ayala et al., 2001; Heyman et al., 1971; 
G. Howard et al., 2016; V. J. Howard, 2013; V. J. Howard et al., 2011; Rosamond et al., 1999). 
Additionally, dementia incidence is consistently found to be highest among blacks, with modest 
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estimates predicting that blacks are at 40% higher (ranges from 14% to 100%) dementia risk 
compared with whites (D. Barnes et al., 2009; Katz et al., 2012; Mayeda et al., 2016; Miles et al., 
2001). Finally, vascular dementia accounts for a larger proportion of cases in blacks than whites 
(Mayeda et al., 2016; Miles et al., 2001). The reasons behind these persistent racial disparities are 
not fully understood, but it has been suggested that there may be differential exposures or 
susceptibilities to the pathogenic effects of known etiological factors for dementia and stroke 
among blacks and whites, including cerebral small vessel disease (CSVD) (F Gottesman et al., 
2015; Gulli et al., 2016; Mayeda et al., 2016; Miles et al., 2001).  
Even prior to the onset of later clinical events and outcomes noted above, blacks appear to 
be at a higher risk for detrimental subclinical brain changes that presage stroke, cognitive 
impairment, and dementia (F Gottesman et al., 2015). For example, studies have found 
associations between black race and reduced cerebral vascular reactivity (Hurr et al., 2015), 
increased burden of white matter hyperintensities (WMH) (B Zahodne et al., 2015; Brickman et 
al., 2008; Hannah Gardener et al., 2012; R. F. Gottesman et al., 2010; Nyquist et al., 2014), 
increased WMH progression (F Gottesman et al., 2015; R. F. Gottesman et al., 2010), a higher 
prevalence of subclinical brain infarcts (Bryan et al., 1999; F Gottesman et al., 2015; G. Howard 
et al., 1998) and increased cerebral atrophy (B Zahodne et al., 2015; F Gottesman et al., 2015). 
Indeed, only a few studies have found no racial differences in indicators of brain health (Liu, Allen 
et al. 2015)(Aggarwal, Wilson et al. 2010)(B Zahodne et al., 2015)(Bryan, Cai et al. 
1999)(Jennings et al., 2013), including those reporting no racial differences in WMH (Liu, Allen 
et al. 2015)(Aggarwal, Wilson et al. 2010), subclinical brain infarcts (B Zahodne et al., 
2015)(Bryan, Cai et al. 1999), and global cerebral blood flow (Jennings et al., 2013). However, 
little is known about racial differences in brain health during midlife. For example, with the 
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exception of two of the above studies (Hurr et al., 2015; Jennings et al., 2013), all of the above 
research has been conducted on populations over the age of 65 years.  
In view of the above, cumulative evidence thus suggests that among older adults, there 
appear to be racial differences in some but not all suspected indicators of subclinical brain health 
(B Zahodne et al., 2015; Brickman et al., 2008; Bryan et al., 1999; F Gottesman et al., 2015; 
Hannah Gardener et al., 2012; R. F. Gottesman et al., 2010; G. Howard et al., 1998; Nyquist et al., 
2014). However, current research on indicators of brain health is limited in that most studies have 
focused on older populations (i.e., over 65-years-old) and have primarily measured only WMH. 
The age groups studied previously and the measurement of only WMH are problematic for several 
reasons. First, examining only older populations raises the problem of survival bias, and further 
limits our understanding of the early disease process. This is particularly important to consider 
when examining racial differences because blacks are at higher risk of disease morbidity and 
mortality than whites (J. Xu, Kochanek, Murphy, & Tejada-Vera, 2016). The blacks who are 
surviving into old age are likely to be relatively healthier than blacks who do not survive into old 
age. As a result, when studies of brain health outcomes are completed in older adult populations, 
the risk profiles of those most vulnerable to pathogenic disease processes are not fully captured. 
The findings from studies in older populations may also not be generalize to all blacks, and they 
may omit a portion of the population that may benefit the most from preclinical prevention and 
intervention strategies. Moreover, in our previous review, we found that there appeared to be an 
age dependent relationship between female sex and markers of cSVD (Jorgensen, 2018; Lisabeth 
& Bushnell, 2012). The interactions between race, sex, and markers of brain health are not well 
studied in younger populations. Yet, we had found consistent evidence among adults > 60 years 
of age for an association between female sex and having higher more markers of cSVD (Longstreth 
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et al., 1998; E. J. van Dijk et al., 2008; Vermeer et al., 2002) but in studies with younger mean 
ages female sex was not associated with cSVD. . Second, WMH are a marker of late-stage CSVD, 
and they are most prevalent after age 65 (Pantoni, 2010). Examining only WMH may be biasing 
the literature to reflect pathology for those who survive long enough to develop WMH, adding to 
the possibility of survivor bias. Additionally, WMH take many years to develop and reflect largely 
irreversible disease processes (Pantoni, 2010). When WMH develop, there is already advanced 
parenchymal damage, reduced cerebral blood flow, and abnormalities of the small penetrating 
vessels (arteriolar thickening, tortuous vessels, and venular collagenosis) (Pantoni, 2010). 
Therefore, WMH are not ideal to target for treatment because the underlying pathology may be 
irreversible or difficult to halt.  
Besides WMH, there are many other markers of brain health that are thought to indicate 
early damage and are related to aging, cognitive decline, dementia risk, stroke risk, and CSVD 
processes  (Appelman et al., 2009; Pantoni, 2010; Peres, De Guio, Chabriat, & Jouvent, 2016; 
Smith et al., 2015; Walhovd et al., 2005; Joanna M Wardlaw, Colin Smith, & Martin Dichgans, 
2013). Some of these markers include cortical white matter volume (A.-T. Du et al., 2005; 
Gunning‐Dixon, Brickman, Cheng, & Alexopoulos, 2009; Guttmann et al., 1998; Smith et al., 
2015; Walhovd et al., 2005), hippocampal volume  (Cuénod et al., 1993; Jack, Petersen, O'brien, 
& Tangalos, 1992; Schuff et al., 2009; Y. Xu et al., 2000), amygdala volume (Cuénod et al., 1993; 
Jack et al., 1992; Y. Xu et al., 2000), cortical thickness (Lemaitre et al., 2012; Smith et al., 2015; 
Storsve et al., 2014), cortical surface area (Lemaitre et al., 2012; Storsve et al., 2014) and cerebral 
blood flow (CBF) (Girouard & Iadecola, 2006; Jennings et al., 2013; Shaw et al., 1984). Racial 
differences in the above brain health markers have not been thoroughly examined. Examining 
whether racial differences in brain health markers are evident at midlife will help to identify 
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potential starting points for the disparities in stroke and dementia seen later in life. Furthermore, 
these early markers of brain health potentially reflect a more reversible disease state where 
intervention may lead to prevention or delay of progression to dementia or stroke events.  
Accordingly, this study tested cross-sectional relationships between race and preclinical 
brain health metrics that are associated with early risk and that often appear prior to the onset of 
WMH and late stage outcomes (e.g. stroke and dementia) in a middle-aged population. We 
expected that middle-aged blacks (aged 30-54 years) would have comparatively worse brain health 
(e.g. reduced cerebral blood flow, lower brain volumes) than same-aged whites. Second, we tested 
whether these differences could in part be explained by demographic factors. Finally, we explored 
whether racial differences in brain health differed by sex. If so, this could help to identify people 
at risk for early detrimental brain changes.   
3.3 METHODS 
3.3.1 Sample selection 
The sample for the present study derived from a combination of two parent samples of midlife and 
community dwelling adults who were recruited by mass-mail solicitations to residents of Western 
Pennsylvania, USA (see Figure 3.1). The parent studies were the Adult Health and Behavior 
project, phase-II (AHAB-II; February 2008 to August 2011)(Gianaros et al., 2014) and the 
Pittsburgh Imaging Project (PIP; August 2008 to October 2014)(Lockwood, Marsland, Cohen, & 
Gianaros, 2016). The total AHAB-II sample consisted of 490 adults. The total sample for PIP 
consisted of 331 adults. There were 44 adults who participated in both PIP and AHAB-II, and 
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these participants’ data were only included in the AHAB-II sample for this analysis. The total 
combined sample was 777 adults. Race was coded as black and white, with people of other races 
and ethnicities not included in the analysis (n=30). 
Adults with any of the following conditions were excluded from participating in either 
study: (1) History of clinical CVD or a CVD event, including Stage II hypertension, stroke, 
myocardial infarction, congestive heart failure, or arrhythmia. (2) Chronic kidney disease, a liver 
condition, or a chronic lung disease. (3) Type I or II diabetes in PIP or insulin-dependent 
diabetes/fasting glucose > 126mg/dL in AHAB II. (4) Any neurological or cerebrovascular 
disorder. (4) Pregnancy or lactation. (5) Claustrophobia. (6) Presence of medical devices, implants, 
or other metal objects in or on the body that could not be removed, tattooed eyeliners, or a body 
habitus prohibiting MR scanning. (7) Any current use of psychotropic prescriptions, or 
medications for insulin, glucocorticoids, arrhythmias, hypertension, lipids, and weight-loss. 
Additionally, PIP had the following additional exclusionary criteria that did not overlap with 
AHAB-II: prior cardiovascular surgery, cancer, cerebrovascular trauma, neurosurgery, and color-
blindness. AHAB-II participants had to be working at least 25 h/week outside of the home. AHAB-
II participants also had the following exclusionary criteria that did not overlap with PIP: (1) alcohol 
consumption > 5 portions 3 times or more/week; (2) use of fish-oil supplements (fish-oil, algae, 
algal oil, or docosahexaenoic acid supplements); and (3) shift work. 
3.3.2 Magnetic Resonance Imaging (MRI) 
High resolution T1-weighted structural MRI data were collected in both PIP and AHAB-II using 
the same magnetization-prepared rapid gradient echo sequence (MPRAGE) on a 3T Trio TIM 
scanner (Siemens, Erlangen, Germany), which was equipped with a 12-channel head coil. MRI 
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data were preprocessed and analyzed with methods published previously (Marsland, 2015).  The 
FreeSurfer 5.3.0 software package (http://surfer.nmr.mgh.harvard.edu) was used to measure 
cortical surface area, cortical thickness, and volumetric data (Fischl and Dale, 2000). Cortical 
thickness is a measure of the combined thickness of the layers of the cerebral cortex. Cortical 
thickness is influenced by the number and the size of cells within a column, packing density, as 
well as by the number of synaptic connections and the extent of axonal myelination (Rakic 1988; 
Eickhoff et al. 2005). Cortical surface area is a measure corresponding to the number of folds in 
the cortex. There is evidence to suggest that cortical thickness and cortical surface area are 
differentially affected in normal aging (Lemaitre et al., 2012) and dementia (Dickerson et al., 
2009). Brain regions were chosen a priori because of known relationships with aging, cognitive 
decline, and dementia risk.  
Resting cerebral blood flow (CBF) images were acquired with a pulsed arterial spin-
labeling (PASL) sequence using a flow-sensitive alternating inversion recovery method (S. G. 
Kim, 1995), specifically applying a saturation pulse 700ms after an inversion pulse. To reduce 
transit artifact, a 1000ms delay separated the end of the labeling pulse and the time of image 
acquisition. Resting CBF image acquisition parameters were: field of view (FOV)=240×240mm, 
matrix size=64×64, repetition time (TR)=4sec, echo time (TE)=18ms, and flip angle (FA)=90°. 
Twenty-one slices (5mm thick, 1mm gap) were acquired sequentially in an inferior-to-superior 
direction, yielding 80 total CBF images (40 labeled, 40 unlabeled; 2 initial discarded images 
allowing for magnetic equilibration).  
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3.3.3 Covariates  
Several variables were considered that might contribute to associations between black race, brain 
structure. These included age (years), sex, years of education, and income adjusted for household 
size.  
3.3.4 Statistical Analysis 
Descriptive statistics comparing demographics, brain health measures, and cardiovascular risk 
factors by “blacks” to “white” groups were completed first.  Linear regression was used to assess 
whether the association between brain health and race could be accounted for demographic 
differences. All regression models were adjusted for study (AHAB-II or PIP). Regression models 
with volume and surface area were adjusted for intracranial volume (ICV). Model 1 was adjusted 
for study and ICV or global CBF where appropriate. Model 2 included additional adjustment for 
age and sex. Model 3 included all adjustments in model 2, along with years of education and 
income adjusted for the number of people in the household (family adjusted income). Model 4 
included all of the adjustments made in model three and added an adjustment for current smoking 
(yes/ no). All assumptions of normality and independence were met. Finally, a sex stratified 
analysis was completed to examine whether differences in brain health by race were similar of 
different across sex groups. All analyses were conducted with SAS, version 9.4 (SAS Institute 
Inc., Cary, NC). 
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3.3.5 Supplemental Analyses  
In a post hoc analyses we examined entorhinal cortex volume as an additional outcome due to role 
in memory and hypothesized relationship with dementia (Braak & Braak, 1995; A. Du et al., 2004). 
For completeness, we also examined whether traditional risk factors for stroke (hypertension, 
hyperlipidemia, diabetes mellitus and obesity)(Romero, Morris, & Pikula, 2008) would attenuate 
any of the observed differences between blacks and whites. Systolic blood pressure (mm Hg), 
diastolic blood pressure (mm Hg), total cholesterol (mg/dL), blood glucose (mg/dL), and BMI 
(kg/m2) were added to the fully adjusted model. As described previously (Jennings et al.), 
components were assessed in the morning after a 12 hour, overnight fast. Prior to analysis: 
cholesterol and glucose were winsorized at the 1st and 99th percentiles. All values were 
standardized, and z-scores were used in the modeling.   
3.4 RESULTS 
3.4.1 Population Characteristics 
There were many differences in the baseline characteristics between the blacks and whites in the 
sample (table 1). Black participants were less likely to be male, were older, had fewer years of 
schooling, a lower family adjusted income and more likely to smoke (all p’s <0.05). 
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3.4.2 Brain health outcomes 
In unadjusted bivariate relationships, blacks had significantly lower mean cortical white matter 
volume, hippocampal volume, amygdala volume, cortical surface area, cortical thickness, gray 
matter volume, and cortex volume (p<0.001 for all). However, global CBF was not significantly 
different by race (p=0.71). Also, blacks on average had significantly smaller intracranial volumes 
(p<0.0001). 
The results from the linear regression analysis show that in fully adjusted models, 
differences by race in several brain areas were statistically significant. On average, black 
participants have 0.40 cm3 smaller hippocampus, 42.16 cm2 less surface area, 0.04 mm thinner 
cortex, 21.17 cm3 smaller cortex, and 24.71 cm3 less gray matter volume (all p’s <0.001) than 
whites after adjusting for study, intracranial volume, sex, age, years of schooling, family income, 
and current smoking. Significant differences in cortical white matter volume and amygdala volume 
were attenuated and became non-significant after adjustment for education and family income 
(p=0.11 and p=0.127, respectively); suggesting that socioeconomic status (SES) partly accounts 
for race differences in cortical white matter and amygdala volumes. The additional adjustment for 
current smoking had minimal impact on the estimates. Cerebral blood flow measures were not 
found to be significantly related to race in any models. 
3.4.3 Sex stratified analysis 
Demographic differences were similar to what was found in the total population, both male and 
female black participants had fewer years of schooling, a lower family adjusted income and were 
more likely to smoke (all p’s <0.001). Black men had an older mean age than white men, but this 
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difference was not statistically significant. Although, both black males and black females had older 
mean ages than their white counterparts, the age differences was not significant either sex strata 
(both p’s<0.05). 
In examining associations with markers of brain health in sex stratified, minimally adjusted 
models, we found similar trends from the total population in each sex. Black men, on average, had 
significantly less cortical white matter volume, amygdala volume, hippocampal volumes, cortical 
surface area, cortical thickness, gray matter volume, and cortex volume (all p’s<0.05). Global CBF 
was not significantly different (p=0.39). We found similar trends but smaller effect sizes in 
females. However, there were no significant differences in cortical white matter volume (p<0.12) 
or amygdala volume (p<0.28) found between black and white women. Global CBF was not 
significantly different from whites in males or females. On average, the racial difference in brain 
health markers was greater in males compared to females; the only exception being cortical 
thickness where the racial difference in cortical thickness was greater in females. There were 
minimal differences (less than 10%) in the betas for cortical white matter volume.  
3.4.4 Supplemental Analyses 
In a supplemental analysis we examined entorhinal cortex volume as an additional outcome. 
Entorhinal cortex was added because the entorhinal cortex and the hippocampus are essential parts 
of the medial temporal lobe system that supports declarative memory (Braak & Braak, 1995). It 
has been hypothesized that AD starts in the entorhinal cortex before spreading to the hippocampus 
and eventually to the cortex (Braak & Braak, 1995). Also the entorhinal cortex has been found in 
some studies to have a higher rate of atrophy than the hippocampus(A. Du et al., 2004). We found 
that black participants on average had significantly lower mean entorhinal cortex volume at 3.45 
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cm3 (95% CI: 3.35, 3.54) compared to 4.00 cm3 (95% CI: 3.95, 4.06) in white participants. In fully 
adjusted models, the difference in mean entorhinal cortex volume between blacks and whites was 
attenuated but remained significant at -0.35 cm3 (95% CI: -0.47, -0.23). Furthermore, black males 
compared to white males had a smaller mean entorhinal cortex volume -0.47 cm3 (95% CI: -0.67, 
-0.28); this trend was similar but slightly lower in females -0.29 cm3 (p =0.171 for race by sex 
interaction term). Age was not found to be a significant predictor of entorhinal cortex volume in 
fully adjusted models (p=0.16), so race differences in years of aging was not calculated.  
Additionally, we examined whether the addition of traditional stroke risk factors 
(hypertension, hyperlipidemia, diabetes mellitus, and obesity) to the model would further attenuate 
any of the observed differences in brain health markers. We found that the addition of blood 
pressure, total cholesterol, blood glucose and BMI had minimal effect on the beta for race in 
models of cortical surface area, gray matter volume, and cortical volume (table 3.iv). The addition 
of these variables also slightly increased the difference in the beta for race in models of 
hippocampal volume and entorhinal cortex. The beta for black race was attenuated by 25% in 
models of cortical thickness after the addition of stroke risk factors. A more in-depth investigation 
of potential mediating factors is presented in chapter 4 of this dissertation.  
3.5 DISCUSSION 
In this cross-sectional study of midlife adults, race was significantly related to several brain health 
markers, except for CBF measures. Relationships between race and both cortical white matter 
volume and amygdala volumes were attenuated and became non-significant after adjustment for 
socioeconomic status measures (education and income). The latter finding indicates that social 
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factors, such as education and income, may contribute to racial differences in brain health. 
Furthermore, in sex stratified models, we found similar trends in both sexes, but differences 
between black and white men tended to be greater than those among women. Together, these 
findings agree with other epidemiological evidence regarding relationships of race and subclinical 
brain health (B Zahodne et al., 2015; Brickman et al., 2008; Bryan et al., 1999; F Gottesman et al., 
2015; Hannah Gardener et al., 2012; R. F. Gottesman et al., 2010; G. Howard et al., 1998; Nyquist 
et al., 2014). This work also adds to the current literature by focusing on midlife individuals and 
markers of early brain health prior to late stage disease seen in older populations.  
Very few studies have examined relationships with brain health markers and race in 
middle-aged populations. Assuming a linear decline with age, we found that mean racial 
differences in hippocampal volume remained in fully adjusted models and were equivalent to 
29.04 years of aging (see table 3.7). Similarly, we found that mean differences in cortical surface 
area, cortical thickness, cortex volume, and gray matter volume that were equivalent to 9.47, 10.66, 
9.20, and 13.96 years of aging, respectively which were not accounted for by age, sex, ICV, study, 
education, family adjusted income, or current smoking. These are large effect sizes for an 
otherwise healthy middle-aged population. For example, these estimates exceed the racial 
difference in life expectancy, where blacks born in the 1970’s are expected to have a ~6.5 year 
short lifespan than whites (NHCS, 2017). Additionally, we found no racial differences in CBF 
measures which is consistent with findings from other studies (Hurr et al., 2015; Jennings et al., 
2013; Selim et al., 2008). These patterns of findings suggest that indicators of morphology, such 
as volume, may be independent of CBF or may be more susceptible to risk factors in midlife, while 
markers such as CBF may be more resilient to change. In support of this, a recent study illustrated 
that CBF values were independent of concurrent age-related tissue volume reduction, finding that 
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perfusion can remain unaltered in regions of significant tissue atrophy (Chen, Rosas, & Salat, 
2011). 
Currently, there are many studies supporting a relationship between CSVD and measures 
of brain atrophy (Joanna M Wardlaw, Eric E Smith, et al., 2013). Relatedly, both hippocampal and 
amygdala volumes are known to decrease with normal aging (Blatter et al., 1995; Mueller et al., 
1998; Walhovd et al., 2005). In examining the Pearson correlations with age, we found all brain 
health markers to be significantly correlated with age (table 3.ii, appendix). The strongest 
correlations with age were cortical thickness and surface area (-0.24 and -0.21, respectively). The 
correlations with age and cortical white matter volume, amygdala volume, hippocampal volumes, 
and CBF measures were similar (appendix table 3.ii). We observed that age was significantly and 
inversely related to all of the brain health markers (appendix table 3.i). Each year in aging was 
associated with a 0.77 cm3, 0.007 cm3, 0.014 cm3 reduction in cortical white matter, amygdala 
volume, and hippocampal volume, respectively (Table 3.7). We also observed a 4.45 cm2 reduction 
in cortical surface area, a 0.003 mm reduction in cortical thickness, a 1.77 cm3, reduction in cortex 
volume, a 2.3 cm3 reduction in grey matter volume, and a 0.2 ml per min per 100g reduction in 
global blood flow per each year of aging (Table 3.7). The reduction is cortical thickness found 
here is similar to what was found in the Smith et al. paper (mean age 58 years +/- 8), where for 
every additional 10 years of age, the cerebral cortex was 0.026mm thinner (95% CI = 0.019–0.033) 
(Smith et al., 2015). 
Interestingly, smaller hippocampal and amygdala volumes are found in people with 
dementia (Cuénod et al., 1993; Jack et al., 1992; Y. Xu et al., 2000), as well as in those with mild 
cognitive impairment who are at a higher risk of developing dementia (A. Du et al., 2001; Frankó, 
Joly, & Initiative, 2013; Y. Xu et al., 2000). Moreover, longitudinal studies of the brain have found 
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that lower hippocampal and amygdala volume increase the risk of developing dementia in 
cognitively normal adults (den Heijer et al., 2006; A. Du et al., 2001; Kaye et al., 1997). For 
example, Den Heijer et al. found that compared with those remaining free of dementia, baseline 
hippocampal and amygdala volumes were 17% smaller in persons who received a clinical 
diagnosis of dementia within 2 to 3 years after MRI and still 5% smaller in those whose conditions 
were diagnosed 6 years after MRI. Similarly, increasing hippocampal volume has been related to 
improvements cognitive functioning (Maass et al., 2015). The relationship between amygdala and 
hippocampal size in the literature, along with our findings that blacks have smaller hippocampi, 
may indicate that there is a higher risk for dementia in this group that is present even at middle 
age. Finally, the cross-sectional nature of this study prevents us from measuring brain atrophy per 
se; however, brain volumes adjusted for ICV are commonly used as a surrogate marker for brain 
atrophy.  
The specific morphologic findings of this study are different than the four previous studies 
that have examined relationships between race and differences in brain volumes in healthy older 
populations (B Zahodne et al., 2015; Brickman et al., 2008; Knopman et al., 2005; Liu et al., 2015). 
Knoppman et. al found that race was not significantly associated with ventricular size or sulci size 
scores after age, race, and sex adjustments in the ARIC study (Knopman et al., 2005).  Liu et al. 
found no racial differences in grey matter atrophy (p=0.4) (Liu et al., 2015). Both Brickman et al. 
and Zahdone et al. examined relationships in the Washington Heights-Inwood Columbia Aging 
Project (WHICAP) study (mean age >80 years old). Zahodne et al. reported that blacks had greater 
hippocampal volumes and lower cortical thickness (B Zahodne et al., 2015). Similarly, Brickman 
et al. found that black participants had larger relative brain volumes (p<0.001), smaller ventricles 
(p=0.046), and more severe WMH burden (p < 0.001) than whites (Brickman et al., 2008). 
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Brickman also found no significant differences in hippocampal volume (p=0.482). All of these 
studies used quantitative methods except for Knoppman et al. which used a 10-point scale 
categorized by two raters (Knopman et al., 2005). A major difference is that these studies were 
carried out in much older populations and therefore could be the result of survival bias where 
blacks surviving into older age may be more resilient to the disease process. This bias could 
diminish the differences in brain health between blacks and whites. Our study, with a mean age 
that is 25 to 40 years younger than the other studies found that blacks had smaller hippocampal 
brain volumes, less surface area, and lower cortical thickness when compared to whites 
independent of study, ICV, age, sex, years of schooling, and family income. However, longitudinal 
studies starting in midlife are needed to examine whether the rate of atrophy is different by racial 
group or whether the smaller volumes observed are a result of developmental processes. Despite 
not knowing the cause of this difference, the smaller the size of the hippocampus confers a higher 
risk of developing dementia (den Heijer et al., 2006) and should not be overlooked. 
In this analysis we found that the black white differences in brain health seemed to be 
attenuated in the female sex group. This is interesting and may indicate a potential protective effect 
of female sex on brain health. There are known sex differences in stroke, dementia risk, markers 
of cSVD and brain structure(Cosgrove, Mazure, & Staley, 2007; Jorgensen, 2018). In our previous 
review, we found that there appeared to be an age dependent relationship between female sex and 
markers of cSVD (Jorgensen, 2018; Lisabeth & Bushnell, 2012). We had found consistent 
evidence among adults > 60 years of age for an association between female sex and having higher 
more markers of cSVD (Longstreth et al., 1998; E. J. van Dijk et al., 2008; Vermeer et al., 2002). 
However, in the Jorgensen et al. review, we also found results in studies with a younger mean age 
that female sex was not associated with cSVD markers.(Jorgensen, 2018) This raises the possibility 
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that relationships between cSVD disease markers and sex may differ by age, with sex-related 
effects on SBI stronger for older as compared to younger subgroups. These findings mirror age 
and sex interactions found in stroke incidence, whereby younger women are at lower risk of stroke 
than men, but older post-menopausal women are at greater risk of stroke than men.(Lisabeth & 
Bushnell, 2012) The reasons for such sex-related differences and the interaction with age are not 
clear, but they could be due to differences in hormonal profiles and their changes over time, and/or 
in overall disease burden in vascular districts outside the brain.  
Determining what factors contribute to differences in brain health is important to 
understanding the disease etiology and determining the best ways to help prevent the progression 
and decrease racial disparities in brain health. Here we found that socioeconomic factors such as 
education and income attenuated the relationship of race and both cortical white matter volume 
and amygdala volume. These findings agree with other work linking SES to brain structure and 
function (Gianaros et al., 2017) and should be investigated further.  
In conclusion, our study found that there are racial differences in morphologic markers of 
brain health but not in CBF in a middle age population. Additionally, that socioeconomic status 
may attenuate some of these differences. These findings were consistent but attenuated in sex 
stratified analyses. Our study had several strengths, including a large sample size, relatively 
healthy population, and the examination of many markers of brain health. However, our study is 
limited by a cross-sectional design and future longitudinal studies should be completed to confirm 
these findings.  
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3.6 TABLES AND FIGURES 
 











Table 3.1 Population Characteristics by Race 
  
  Black   (n=154) 
White  
(n=593)   P VALUE 
Male  (%) 38.31 49.58   0.0126 
            
Age in years (mean) 42.99 41.55   0.0239 
  (min, max) (30, 54) (30, 54)     
            
Years of School (mean) 15.05 17.06   <.0001 
  (min, max) (9, 24) (9, 24)     





(mean) 28.73 34.77   <.0001 
(min, max) (14.52, 51.11) (13.84, 57.74)     
            
Current Smoker  (%) 32.47 17.74   0.0003 
            





Table 3.2 Brain Health Markers by Race 
    Black White   P VALUE 
Cortical White Matter Vol, cm3 
(n) 142 572     
mean 460.2 492.2   <.0001 
95% CI (450.4, 470.0) (487.4, 496.9)    
Hippocampal Vol, cm3 
(n) 142 572     
mean 7.8 8.4   <.0001 
95% CI (7.6, 7.9) (8.4, 8.5)     
 
Amygdala Vol, cm3 
(n) 142 572     
mean 3.1 3.2   <.0001 
  95% CI (3.0, 3.1) (3.2, 3.3)     
Cortical Surface Area, cm2 
(n) 143 562     
mean 1606.44 1718.51   <.0001 
95% CI (1579.0, 1633.8) (1704.8, 1732.2)     
Cortical thickness, mm 
(n) 143 572     
mean 2.46 2.51   <.0001 
95% CI (2.43, 2.47) (2.50, 2.52)     
Cortex volume, cm3 
(n) 142 572     
mean 431.5 476.3   <.0001 
95% CI (423.8, 439.2) (472.1, 480.4)     
Gray matter volume, cm3 
(n) 142 572     
(mean) 608.4 665.5   <.0001 
95% CI (598.0, 618.8) (659.9, 671.0)     
Global CBF (ml /min/100g) (n) 139 562     mean 59.3 58.4   0.709 
  95% CI (57.3, 61.28) (57.6, 59.3)     
Intracranial volume, cm3 
(n) 142 572     
mean 1242.7 1363.1   <.0001 
95% CI (1203.1, 1282.3) (1342.1, 1384.1)   
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Table 3.3 Linear regression models for brain health measure by race 
Brain Health Measure 
Model 1 Model 2  Model 3 Model 4 
B  95% CI  B 95% CI  B 95% CI  B 95% CI 
Cortical White Matter 
Vol, cm3 -11.11** (-18.74, -3.48) -10.10** (-17.74, -2.47) -6.56 (-14.64, 1.51) -5.68 (-14.32, 2.96) 
Amygdala Vol, cm3 -0.067* (-0.13, -0.004) -0.07* (-0.13, -0.002) -0.05 (-0.12, 0.02) -0.05 (-0.12, 0.02) 
Hippocampal Vol, cm3 -0.43*** (-0.56, -0.29) -0.41*** (-0.55, -0.28) -0.40*** (-0.55, -0.25) -0.40*** (-0.56, -0.25) 
Cortical Surface area 
cm2 -56.11*** (-79.01, -33.20) -50.92*** (-73.04, -28.79) -42.77*** (-66.19, -19.35) -42.16** (-67.28, -17.03) 
Cortical Thickness, mm -0.06*** (-0.074, -0.038) -0.05*** (-0.06, -0.029) -0.04*** (-0.06,  -0.02) -0.04*** (-0.062, -0.023) 
Cortex Vol, cm3 -26.85*** (-33.14, -20.57) -24.32*** (-30.13, -18.50) -21.17*** (-27.32, -15.02) -21.17*** (-27.67, -14.68) 
Gray Matter Vol, cm3 -32.10*** (-40.00, -24.21) -29.24*** (-36.38, -22.10) -25.16*** (-32.72, -17.60) -24.71*** (-32.69, -16.72) 
Global CBF 
(ml/min/100g) 0.48 (-1.54, 2.49) 0.14 (-1.72, 1.99) 0.4 (0.01, -1.57) 0.77 (-1.33, 2.87) 
B reported for African American race , * p<0.05, **p<0.01, ***p<0.001         
Model 1 adjusted for study, ICV if volume or surface area measure is outcome, global CBF if frontal CBF is outcome.  
Model 2 = Model 1 + sex and age. 
Model 3 = Model 2 + years of schooling and family income.  





Table 3.4 Population Characteristics by Sex and Race 
 
    Men Women 
    Black   White (n=294) p value 
Black   White 
(n=299) p value (n=59) (n=95) 
Age in years mean (std) 42.17 (6.06) 40.68 (7.26 0.141 43.51 (7.07) 42.41 (6.90) 0.1806 (min, max) (30, 54) (31, 54)   (30, 54) (30, 54)   
                
Years of School mean (std) 14.64 (2.61) 17.42 (2.93) <.0001 15.31 (2.58) 16.71 (2.75) <.0001 (min, max) (9, 24) (10, 24)   (9, 21) (10, 24)   
                
Family Income Adj 
for household number 
mean (std) 29.75 (8.01) 35.20 (7.30) <.0001 28.11 (6.75) 34.35 (7.31) <.0001 
(min, max) (14.97, 47.07)  (13.84, 57.74)   (14.52, 51.11) (15.54, 51.44)   
                














Brain Health Measure 
Total Sample Males Females 
B  95% CI B  95% CI B  95% CI 
Cortical White Matter Vol, cm3 -11.11** (-18.74, -3.48) -16.41** (-28.28, -4.54) -8.00 (-18.00. 2.00) 
Amygdala Vol, cm3 -0.067* (-0.13, -0.004) -0.12* (-0.22, -0.03) -0.04 (-0.13, 0.04) 
Hippocampal Vol, cm3 -0.43*** (-0.56, -0.29) -0.69*** (-0.92, -0.46) -0.26** (-0.43, -0.10) 
Cortical Surface area cm2 -56.11*** (-79.01, -33.20) -68.3*** (-103.79, -32.81) -52.95*** (-82.35, -23.54) 
Cortical Thickness, mm -0.06*** (-0.074, -0.038) -0.05** (-0.07, -0.02) -0.06*** (-0.08, -0.03) 
Cortex Vol, cm3 -26.85*** (-33.14, -20.57) -31.01*** (-40.94, -21.09) -25.67*** (-33.60, -17.73) 
Gray Matter Vol, cm3 -32.10*** (-40.00, -24.21) -38.34*** (-50.78, -25.91) -30.70*** (-40.39, -21.00) 
Global CBF (ml/min/100g) 0.48 (-1.54, 2.49) -0.92 (-3.68, 1.84) 0.08 (-2.48, 2.63) 
B reported for African American race , * p<0.05, **p<0.01, ***p<0.001   
Model is adjusted for study, ICV if volume or surface area measure is outcome. 
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Table 3.6 Race differences in Brain Health Measures by Sex in fully adjusted models 
 
Brain Health Measure 
 
Females Percent Difference in Beta (male to female) 
p-value for sex*race 
interaction term Males 
 
B 95% CI B 95% CI   
Cortical White Matter 
Vol, cm3 
-11.47 (-25.09, 2.14) -1.12 (-12.60, 10.36) 90.22 0.15 
Amygdala Vol, cm3 -0.09 (-0.20, 0.02) -0.02 (-0.11, 0.07) 75.97 0.221 
Hippocampus Vol, cm3 -0.57** (-0.83, -0.31) -0.30** (-0.49, -0.10) 48.16 0.012 
Cortical Surface area 
cm2 
-57.25** (-97.15, -17.35) -32.48 (-65.55, 0.59) 43.27 0.461 
Cortical Thickness, 
mm 
-0.03 (-0.06, 0.00) -0.05*** (-0.07, -0.02) -62.57 0.655 
Gray matter Vol, cm3 -29.08*** (-42.42, -15.74) -21.71*** (-31.76, -11.66) 25.34 0.417 
Cortex Vol, cm3 -24.23*** (-34.94, -13.52) -19.06*** (-27.37, -10.75) 21.34 0.469 
Global CBF 
(ml/min/100g) 
0.04 (-3.18, 3.27) 0.78 (-2.07, 3.64) - 0.601 
B reported for black race, * p<0.05, **p<0.01, ***p<0.001 







Table 3.7 Racial difference in brain health converted to difference in aging (years) in fully adjusted model 
 




years of aging 
Cortical White Matter Vol, 
cm3 -5.67 (4.40) 0.197 -0.77 (0.24) 0.0013   n/s 
Amygdala Vol, cm3 -0.05 (0.04) 0.1491 -0.007 (0.002) 0.0002   n/s 
Hippocampal Vol, cm3 -0.40 (0.08) <.0001 -0.014 (0.004) 0.0013   29.04 
Cortical Surface area cm2 -42.16 (12.80) 0.001 -4.45 (0.69) <.0001   9.47 
Cortical Thickness, mm -0.042 (0.01) <.0001 -0.003 (0.0005) <.0001   13.92 
Cortex Vol, cm3 -21.17 (3.30) <.0001 -1.77 (0.18) <.0001   11.96 
Gray Matter Vol, cm3 -24.71 (4.07) <.0001 -2.30 (0.22) <.0001   10.73 
Global CBF (ml/min/100g) 0.77 (1.07) 0.4726 -0.20 (0.06) 0.0007   n/s 
B reported for black race, * p<0.05, **p<0.01, ***p<0.001 





3.7 SUPPLEMENTAL TABLES AND FIGURES 
 





























Age (yrs) -0.1 -0.14 -0.12 -0.07 -0.21 -0.24 -0.26 -0.26 -0.12 
 0.0069 0.0001 0.0014 0.048 <.0001 <.0001 <.0001  <.0001  0.0022 
Years of 
school 
0.15 0.08 0.13 0.16 0.15 0.13 0.2 0.2 -0.02 
  <.0001 0.0302 0.0004 <.0001 <.0001 0.0004 <.0001  <.0001  0.5287 
Family 
Income  
0.19 0.14 0.16 0.21 0.17 0.10 0.19 0.19 -0.08 
 <.0001 0.0003 <.0001 <.0001 <.0001 0.01 <.0001  <.0001  0.0373 
Intracranial 
Volume 
0.73 0.55 0.60 0.53 0.70 0.27 0.79 0.75 -0.34 
  <.0001  <.0001  <.0001  <.0001 <.0001  <.0001  <.0001  <.0001  <.0001  





Table 3.ii Correlations between brain health measures  






























1 0.65 0.65 0.90 0.08 0.83 0.82 0.95 -0.17 0.56 
  <.0001 <.0001 <.0001 0.0399 <.0001 <.0001 <.0001 <.0001 <.0001 
Amygdala 
Vol 
  1 0.71 0.64 0.30 0.71 0.69 0.71 -0.16 0.51 
    <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
Hippocampal 
Vol 
    1 0.65 0.27 0.73 0.70 0.73 -0.16 0.51 
      <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 
Cortical 
Surface Area 
      1 0.05 0.89 0.90 0.94 -0.14 0.59 
        0.1581 <.0001 <.0001 <.0001 0.0002 <.0001 
Cortical 
Thickness 
        1 0.45 0.48 0.29 -0.12 0.29 
          <.0001 <.0001 <.0001 0.0011 <.0001 
Gray Matter 
vol 
          1 0.98 0.96 -0.21 0.65 
            <.0001 <.0001 <.0001 <.0001 
Cortex vol             1 0.95 -0.19 0.65               <.0001 <.0001 <.0001 
Total Brain 
vol 
              1 -0.20 0.64 
                <.0001 <.0001 
Global CBF                 1 -0.20                   <.0001 
Entorhinal 
Cortex vol 
                  1 




Table 3.iii Race differences in Brain Health Measures by study in fully adjusted models 
 
Brain Health Measure 
PIP  AHAB-II Percent Difference in 
Beta (PIP to AHAB) B  SE p-value B  SE p-value 
Cortical White Matter 
Vol, cm3 -7.74 6.14 0.21 
-2.03 6.42 0.752 - 
Amygdala Vol, cm3 -0.04 0.05 0.42 -0.04 0.05 0.449 - 
Hippocampal Vol, cm3 -0.52 0.11 <.0001 -0.26 0.12 0.027 51% 
Entorhinal Cortex vol, 
cm3 -0.36 0.09 <.0001 -0.35 
0.09 <.0001 3% 
Cortical Surface area cm2 -54.43 18.96 0.0044 -27.02 17.88 0.073 50% 
Cortical Thickness, mm -0.04 0.01 0.0098 -0.03 0.01 0.003 33% 
Cortex Vol, cm3 -24.50 4.83 <.0001 -16.28 4.67 0.001 34% 
Gray Matter Vol, cm3 -28.12 5.86 <.0001 -19.03 5.80 0.001 32% 
Global CBF 
(ml/min/100g) -0.05 1.56 0.7383 1.01 1.51 0.619 - 
B reported for black race.        










Fully adjusted model Model + stroke risk factors % change in beta 
for race B 95% CI B 95% CI 
Cortical White Matter 
Vol, cm3 -5.68 (-14.32, 2.96) -5.22 (-14.16 , 3.69) - 
Amygdala Vol, cm3 -0.05 (-0.12, 0.02) -0.07 (-0.14, 0.01) - 
Hippocampal Vol, cm3 -0.40*** (-0.56, -0.25) -0.44*** (-0.60, -0.28) -10% 
Entorhinal Cortex vol, 
cm3 -0.35*** (-0.47, -0.23 -0.38*** (-0.50, -0.26) -9% 
Cortical Surface area 
cm2 -42.16** (-67.28, -17.03) -41.28** (-67.33, -15.23) 2% 
Cortical Thickness, mm -0.04*** (-0.062, -0.023) -0.03** (-0.05, -0.01) 25% 
Cortex Vol, cm3 -21.17*** (-27.67, -14.68) -20.44*** (-27.19, -13.69) 6% 
Gray Matter Vol, cm3 -24.71*** (-32.69, -16.72) -23.96*** (-32.25, -15.67) 3% 
Global CBF 
(ml/min/100g) 0.77 (-1.33, 2.87) 1.00 (-1.17, 3.18) - 
B reported for black race, * p<0.05, **p<0.01, ***p<0.001 












Figure 3.ii Linear regression with 95% CI of hippocampal volume by age (years) and race.  
The mean hippocampal volume for black race (red) is lower than for white race (blue), but this difference narrows in older age groups. 
Effect decreases overtime. P value for interaction of age * race (p=0.0567) in fully adjusted model. 
75 
 RACIAL DIFFERENCES IN BRAIN HEALTH AT MIDLIFE: THE POTENTIAL 
MEDIATING ROLE OF CARDIORESPIRATORY FITNESS AND CARDIOMETABOLIC 
RISK 
4.1 ABSTRACT 
Background: Blacks are at a higher risk than whites for several adverse brain-related outcomes, 
such as stroke and dementia. Due to associations of vascular risk factors with brain health and 
function, racial differences in brain health may result from a greater burden of vascular risk factors 
in blacks. However, vascular risk factors have not been fully tested as possible explanatory factors 
of racial differences in brain health. Further, much of what is known about racial differences in 
brain health is nearly exclusive to those >65 years old.  
Methods: 747 community volunteers (20.6% black) aged 30–54 years old, underwent 
neuroimaging to assess brain morphology. Components of composite cardiometabolic risk score 
(CMR) included: body mass index, waist circumference, high-density lipoproteins, triglycerides, 
glucose, insulin, SBP, and DBP. Cardiorespiratory Fitness (CRF) was calculated from an 
equation derived by (Jurca et al., 2005) based on age, sex, body mass index, resting heart rate, 
and self-reported physical activity level. To test mediation, we used a structural equation model 
and bootstrapping procedures from the PROCESS v2.14 macro. All models were adjusted for 
age, sex, household income, education, current smoking, study and intracranial volume. 
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4.2 INTRODUCTION 
Our previous findings and the cumulative literature evidence suggests that there appear to be racial 
differences in subclinical brain disease markers (B Zahodne et al., 2015; Brickman et al., 2008; 
Bryan et al., 1999; F Gottesman et al., 2015; Hannah Gardener et al., 2012; R. F. Gottesman et al., 
2010; G. Howard et al., 1998; Nyquist et al., 2014). Due to the strong associations between 
vascular risk factors with brain health and function (Khan et al., 2007; S.-A. Kim & Park, 2015; 
Qiu & Fratiglioni, 2015; Whitmer et al., 2005), it is possible that racial differences in brain health 
result from a greater burden of vascular risk factors in blacks (F Gottesman et al., 2015; Heyman 
et al., 1991; V. J. Howard et al., 2011; Mayeda et al., 2016; Miles et al., 2001; Sacco et al., 2001). 
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However, vascular risk factors have not been fully tested as explanatory factors that partly account 
for racial differences in brain health outcomes (F Gottesman et al., 2015).  
Cardiorespiratory fitness (CRF) and cardiometabolic risk (CMR) are both modifiable 
factors that are linked to vascular disease and brain health throughout the lifespan. Furthermore, 
CRF and CMR are related to each other. Longitudinal and cross-sectional studies have found that 
increases in CRF are associated with decreases in CMR components (Artero et al., 2011; Shuval 
et al., 2014). CMR score is predictive of incident diabetes, cardiovascular disease, cerebrovascular 
disease, and stroke (Gami et al., 2007). Independent of race, components of CMR have been 
associated with lower brain volumes(Gunstad et al., 2008) and reduced cortical thickness 
(Krishnadas et al., 2013). Additionally, CMR score has been associated with lower CBF (Jennings 
et al., 2013) and was found to be a significant mediator of relationships between SES and brain 
health (Gianaros et al., 2017). While CMR may be detrimental to brain health, physical activity 
may confer a protection against deteriorating brain health, cognitive decline, and dementia.(Hamer 
& Chida, 2009) Cardiorespiratory fitness (CRF) is a sensitive and reliable measure of habitual 
physical activity ("American College of Sports Medicine Position Stand. The recommended 
quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular 
fitness, and flexibility in healthy adults," 1998; Church, Earnest, Skinner, & Blair, 2007; A. S. 
Jackson, Sui, Hébert, Church, & Blair, 2009; Jurca et al., 2005; Wang et al., 2010). Cross-sectional 
and longitudinal associations are consistently found between higher CRF and greater gray matter 
volume, specifically in the prefrontal cortex and hippocampus (Colcombe et al., 2006; Erickson, 
Leckie, & Weinstein, 2014; Erickson et al., 2011; Hayes, Hayes, Cadden, & Verfaellie, 2013; 
Maass et al., 2015; Ruscheweyh et al., 2011; Weinstein et al., 2012). These links suggest the 
possibility of CRF as a predictor of brain volumes. CRF shows further promise as a potential way 
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to intervene on declining brain volumes. Randomized exercise interventions in middle-aged 
populations have shown the potential of increasing the volume of the hippocampus and prefrontal 
cortex in relatively short periods of time such as 6 months(Colcombe et al., 2006; Ruscheweyh et 
al., 2011) or 1 year(Erickson et al., 2011). Compared to white participants, low CRF has been 
found to be more prevalent among black or African American participants in many epidemiologic 
samples (Swift et al., 2017; Swift et al., 2013). Additionally, studies in individuals with low CRF 
have found independent relationships between race and CMR components, where black race 
remains associated with a greater prevalence of CMR components, seemingly independent of low 
CRF(Swift et al., 2013).  But relationships between CRF and CVD mortality appear to be similar 
in both black and white populations (Swift et al., 2013). In all, the above findings suggest that CRF 
and CMR are related to each other and race, but that independent or synergistic relationships may 
remain. While many studies have examined CMR and CRF independently, it is important to 
determine how these factors may work independently or synergistically to impact brain health. 
Accordingly, this study tested cross-sectional relationships between race, CRF, CMR score 
and subclinical brain abnormalities metrics that are associated with early risk and that often appear 
prior to the onset of WMH and late stage outcomes (e.g. stroke and dementia) in a middle-aged 
population. We examined whether CRF or a composite metric of vascular risk, a CMR score, 
would attenuate any observed race differences in brain health. If so, then this would provide initial 
evidence for the partial contribution of vascular risk to disparities in preclinical brain health 
outcomes. The latter was formally tested using a sequential mediation analysis following a 
structural equation model with nonparametric bootstrapping with 95% confidence intervals for 
indirect mediation effects generated by the bias-corrected method (Shrout & Bolger, 
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2002)(Preacher & Hayes, 2008). This mediation model also allows us to examine the independent 
effects and shared effects of the potential mediators (CRF and CMR). 
4.3 METHODS 
The population sample, covariates, and imaging methods are the same as presented above (section 
3.3 methods). Only brain health measures that were identified as statistically significantly different 
between blacks and whites after adjustment for demographic variables and current smoking 
(hippocampal volume, cortical surface area, cortical thickness, cortex volume, and gray matter 
volume) were evaluated for potential mediation. 
4.3.1 Cardiorespiratory fitness (CRF) 
CRF was calculated from an equation derived by (Jurca et al., 2005) that has been shown to 
significantly correlate with VO2 max (r = .71, p < .001)(Boots et al., 2015). This measure is based 
on age, sex, body mass index, resting heart rate, and self-reported physical activity level, i.e., CRF 
= 18.07+ Male(2.77) – Age in years (.10) – BMI (.17) – Resting Heart Rate (.03) + Self-Reported 
Physical Activity. In AHAB-II only, CRF was derived by averaging the inter-beat interval from 
an un-paced respiration protocol involving EKG monitoring (i.e. HR = 60000/mean IBI) over three 
visits. In PIP, heart rate was measured using Dinamap. The CRF score was converted to a z-score 
and the inverse of this score (e.g. poor CRF) was used in the mediation analysis.  
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4.3.2 Cardiometabolic risk (CMR) score 
As described previously (Jennings et al.), components of the CMR score were assessed in the 
morning after a 12 hour, overnight fast. A composite index of CMR was computed from the 
following variables, as based on prior work (Marsland, McCaffery, Muldoon, & Manuck, 2010): 
body mass index (BMI), waist circumference, high-density lipoproteins (reverse-coded), 
triglycerides, glucose, insulin, SBP, and DBP (mean of 2 consecutive readings obtained in a seated 
position). Prior to analysis: glucose and insulin were winsorized at the 1st and 99th percentiles, 
and logarithm (base 10) transformations were applied to triglyceride and insulin values to correct 
for skewed distributions. A composite CMR index was then derived by averaging the standardized 
(z-score) values of the above variables. A higher CMR index score reflects higher vascular risk, 
comprising higher average values for BMI, waist circumference, high-density lipoproteins, 
triglycerides, glucose, insulin, SBP, and DBP. 
4.3.3 Statistical Analysis 
Descriptive statistics for cardiovascular risk factors and potential mediators CRF and CMR were 
compared by race (blacks versus white) groups were completed first. computed. A series of linear 
regression models were created for each brain health variable.  All regression models were adjusted 
for study (AHAB-II or PIP). Regression models with volume and surface area were adjusted for 
intracranial volume (ICV). Models were also adjusted for age, sex, years of education, income 
adjusted for the number of people in the household (family adjusted income), and current smoking. 
All assumptions of normality and independence were tested and met.  
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4.3.3.1 Mediation testing 
Prior to the mediation analysis, we tested for interaction effects of race on the relationship between 
the potential mediators (CRF and CMR) and brain health to determine if the association of each 
mediator is similar across racial groups. The effects were determined to be similar if the interaction 
term (Mediator *black race predicting the brain outcome) was not statistically significant (p>0.1). 
Structural equation modeling was used to test the hypothesis that CRF score (M1) and CMR (M2) 
statistically mediates the cross-sectional relationship between race (X) and brain health measures 
(Y) found to be statistically different in adjusted models. Associations of race with CRF were 
tested as the effect of X on M1 (X→ M1), corresponding to the “a Path.” Associations of race with 
CMR were tested as the effect of X on M2 (X→ M2), corresponding to the “b Path.” Associations 
of CRF with brain health measures were tested as the effect of M1 on Y (M1→Y), corresponding 
to the “d Path.” Associations of CMR with brain health measures were tested as the effect of M2 
on Y (M2→Y), corresponding to the “e Path.” Associations of CRF with CMR were tested as the 
effect of M1 on M2 (M1→ M2), corresponding to the “f Path.” Associations reflecting the total 
effects of race on brain health measures without controlling for CMR score were tested as the 
unadjusted effects of X on Y (X→Y) or “c Path.” Associations reflecting the direct effects of race 
on brain health measures while controlling for CRF and CMR score were tested as the adjusted 
effects of X on Y (X→Y) or “c’ Path.” Indirect path effects reflecting the association of race and 
brain health measures—as mediated by CRF (X→M1→Y), CMR (X→M2→Y),  and sequentially 
through CRF and CMR (X→M1→ M2→Y)—were tested as the product of the paths (Preacher & 
Hayes, 2008). Statistical testing of mediation was done by nonparametric bootstrapping (5000 
iterations), with 95% confidence intervals (CIs) for indirect mediation effects generated by the 
bias-corrected method (Shrout & Bolger, 2002). We tested the significance of this indirect effect 
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using bootstrapping procedures from the PROCESS v2.14 macro (Hayes, 2012). All mediation 
models were adjusted for age, sex, family income, education, ICV, and study. All analyses were 
conducted with SAS, version 9.4 (SAS Institute Inc., Cary, NC). 
4.4 RESULTS 
4.4.1 Relationships between Race and Cardiovascular disease risk factors and potential 
mediators 
Several differences in cardio-metabolic measures between blacks and whites were observed. 
Blacks had significantly higher SBP, DBP, fasting insulin, and BMI (p<0.05 for all) than whites. 
Blacks also had significantly lower fasting triglycerides and waist circumference when compared 
to whites (both p’s<0.05). There was no difference in fasting HDL or fasting cholesterol (both 
p’s>0.05) (see table 4.1). Blacks also had higher CMR scores and lower CRF (both p’s<.001) (see 
table 4.1). 
4.4.2 Relationships between potential mediators and markers of brain health  
We found that the two potential mediators, poor CRF and CMR score, were significantly positively 
with correlated with each other (rho =0.21, p<.0001). 
In examining relationships between the potential mediators and brain health markers we 
found that poor CRF and CMR score were significantly negatively correlated with all measures of 
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brain health; with the exception of CMR score and cortical thickness (p=0.059) and CMR score 
with hippocampal and entorhinal cortex volume (both p’s>0.05) (see table 4.2).  
4.4.3 Linear regression models of CRF and CMRs  
In linear regression analyses, we found on average, black participants have 0.40 cm3 smaller 
hippocampus, 0.35 cm3 less entorhinal cortex volume, 42.16 cm2 less surface area, 0.03 mm 
thinner cortex, 21.17 cm3 smaller cortex, and 24.71 cm3 less gray matter volume (p<0.001 for all) 
than whites after adjusting for study, intracranial volume, sex, age, years of schooling, family 
income, and current smoking.  
Adjustment for CRF attenuated the beta estimates for race in the models for hippocampal 
volume by 2.4%, entorhinal cortex by 8.57%, cortical surface area by 15.5% and gray matter 
volume by 4.2% but black race remained a significant predictor in each model. The addition of 
CRF had little impact on the relationship between race and cortex volume but it increased the racial 
difference in mean cortical thickness by 17.6%. The increase in the racial difference of cortical 
thickness is inconsistent with the mediation analyses undertaken, and therefore, CRF was not 
tested as a mediator for the relationship between race and cortical thickness.   
After adding the CMR score to the fully adjusted models, the relationship between race 
and hippocampal volume was attenuated by 7.6% cortical surface area by 13.0%, cortex volume 
by 5.9% and gray matter volume by 8.5% but black race remained significant in each model. The 
addition of CMR score had little impact on the relationship between race and cortical thickness 
but increased the difference in entorhinal cortex volume by 5.71%. The increase in the racial 
difference of entorhinal cortex is inconsistent with the current mediation analyses, and therefore, 
CMR was not tested as a mediator for the relationship between race and entorhinal cortex.   
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4.4.4 Interaction effects 
To determine if the effect of each mediator is similar across racial groups we tested for interaction 
effects of race on the relationship between the potential mediators (CRF and CMR) and brain 
health markers. No significant interaction effects were found (p>0.1 for all interaction estimates). 
Although not significant, the interaction between race and CRF on hippocampal volume (F= 2.08, 
p=0.15) indicated that a one standard deviation decrease in CRF was associated with a steeper for 
decline in hippocampal volume for blacks than for whites. Overall, these findings suggest that the 
effect of CRF and CMR on the brain health outcomes does not significantly differ by race, after 
accounting for ICV, study, age, sex, income, education, and current smoking. 
4.4.5 Mediation results 
To investigate the potential mediating role of CRF and CMR score, we hypothesized a sequential 
process to the mediation whereby, poorer CRF would lead to increased CMR score and poorer 
brain health. Testing this sequential mediation chain considers both the correlation between CRF 
and CMR (Pearson correlation =0.21) that testing each mediator independently would ignore. The 
results of the linear regression (table 4.3) only supported testing sequential mediation for 
hippocampal volume, cortical surface area, cortical surface area and gray matter volume. The 
addition of CRF or CMR score to the model of black race and cortical thickness or entorhinal 
cortex volume resulted in a beta larger than the unadjusted beta. This increase in the beta for race 
suggests an effect inconsistent with the mediation analyses undertaken and therefore, cortical 
thickness and entorhinal cortex volume was not pursued in the mediation analysis. 
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A summary of the mediation results in presented in figures 4.1-4.3. Mediation models 
showed a significant indirect effect, with CRF and CMR score partially mediating the association 
of race with cortical surface area (-2.11 cm2 [95% CI: -6.42, -1.08]). CMR score was found to 
mediate the association independent of CRF (-3.31 cm2 [95% CI: -10.32, -1.16]). CRF did not 
independently mediate this association with race and cortical surface area (0.83 cm2 [95% CI: -
2.19, 6.16]). Additionally, we found a similar significant indirect effect, with CRF and CMR score 
partially mediating the association of race with gray matter volume (-0.66 cm3 [95% CI: -2.02, -
0.04]). Likewise, CMR score was found to mediate the association independent of CRF for gray 
matter volume (-1.04 cm3 [95% CI: -3.40, -0.02]). In each of these models, the independent effect 
of CMR score was larger than that of the shared CRF and CMR score path. Finally, we found no 
significant mediation effect of CRF or CMR on hippocampal volumes or cortex volume (all 95% 
CI overlap 0). In sum, CRF and CMR partially mediated the association of race with cortical 
surface area and gray matter volume by 22.79% and 5.98%, respectively. These findings suggest 
that race relates to brain health in part through its association with CRF and CMR score, but not 
through CRF alone. 
4.5 DISCUSSION 
In this cross-sectional study of middle-aged black and white adults, we found that relationships 
between race and both cortical white matter volume and cortical surface area were partially 
mediated through CRF and CMR score. The effect size of CMR score, independent of CRF, was 
consistently larger than the path leading through both CRF and CMR score. But, we also found 
that there remained a significant direct effect of race on hippocampal volume, cortical surface area, 
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cortex volume, gray matter volume and mean cortical thickness that was independent of CRF and 
CMR score. Additionally, we found the effect of CRF or CMR was not significantly different by 
race. Together, these findings agree with other epidemiological findings regarding relationships of 
race, brain health, and vascular disease risk (B Zahodne et al., 2015; Brickman et al., 2008; Bryan 
et al., 1999; F Gottesman et al., 2015; Hannah Gardener et al., 2012; R. F. Gottesman et al., 2010; 
G. Howard et al., 1998; Nyquist et al., 2014). This work also adds to the current literature by 
focusing on midlife individuals and markers of early brain health prior to late stage disease seen 
in older populations.  
Overall, we found several differences in vascular risk factors where blacks tended to have 
more adverse risk factor profiles. Blacks had higher blood pressure, glucose, insulin, BMI, CMR 
scores and lower CRF. However, blacks had lower waist circumference and triglycerides than 
whites. Also, there were no significant differences in HDL or total cholesterol. These findings are 
consistent with what has been found in previous work (as reviewed in Kurian, 2007)(Mensah, 
Mokdad, Ford, Greenlund, & Croft, 2005). In a systematic review of racial differences in vascular 
risk factors, it was found that blacks tend to have more hypertension and diabetes, but differences 
in lipids or BMI/ waist circumference were not consistently found (Kurian & Cardarelli, 2007). 
Furthermore, our finding that blacks have a higher CMR score on average is comparable to 
findings that blacks have an increased clustering of vascular risk factors than whites (Sharma, 
Malarcher, Giles, & Myers, 2004). In order to determine whether the impact of CRF or CMR is 
the same on brain health by race, we tested for interaction effects and found no significant 
interaction effects of race on CRF or CMR (all p’s>0.1).  
Ultimately, in mediation models, we found that CRF and CMR score partially explained 
the relationships between race and cortical surface area and gray matter volume but not the other 
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markers of brain health. Also, there remained a significant direct effect of race on hippocampus 
volume, cortical surface area, and mean cortical thickness that was independent of CMR scores. 
This novel finding suggests several possibilities. First, in the context of race, it is possible that 
CMR may differentially impact brain health in middle age. It is known that cortical thickness and 
cortical surface area are inversely related (Storsve et al., 2014), thought to be genetically unrelated 
(Panizzon et al., 2009), and argued to reflect different morphometric features of 
neurodevelopment, aging, and disease (Storsve et al., 2014)(Dickerson et al., 2009; Ostby et al., 
2009; Panizzon et al., 2009; White et al., 2010; Winkler et al., 2010; Eyler et al., 2011; Lemaitre 
et al., 2012). This may be why CMR mediated the relationship between race and cortical surface 
area, but not cortical thickness. Therefore, managing CMR may be important for preventing 
accelerated aging related declines in cortical surface area, cortical volume and gray matter volume. 
Moreover, it has been shown that improvements in CRF can increase the volume and perfusion of 
the hippocampus and improve cognitive functioning (Colcombe et al., 2006; Erickson et al., 2011; 
Ruscheweyh et al., 2011). Despite CRF only accounting for a small amount of the racial disparity 
in brain health, improving CRF among blacks could be a way of reducing this disparity as it has 
been linked to increasing and preserving brain volumes, especially the hippocampus.  
Second, the impact of race on hippocampal volume, cortical surface area, mean cortical 
thickness, cortex volume, and grey matter volume remains to be explained. Other factors need to 
be examined in order to determine other mediators of the relationship between race and brain 
health. Some factors that should be investigated include subclinical cardiovascular disease 
measures, health behaviors (Durazzo et al., 2014; Erickson et al., 2011), and social factors (stress, 
occupation, and discrimination)(Gianaros et al., 2017). Subclinical cardiovascular disease 
measures (including CAC, IMT, carotid plaque) have been related to poorer cognition and 
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dementia risk in older populations (Kuller et al., 2016; van Oijen et al., 2007; Wendell et al., 2012) 
and it would be important to evaluate if differences in subclinical cardiovascular disease mediate 
the relationship between race and brain health changes. 
In conclusion, our study found that CRF and CMR partially mediated the relationships 
between race and cortical surface area, cortex volume, and grey matter volume but not with other 
markers of brain health. The effect through CMR, independent of CRF, tended to be larger than 
that through CRF and CMR. Our study had several strengths, including a large sample size, 
relatively healthy population, and the examination of many markers of brain health. However, our 
study is limited by a cross-sectional design and future longitudinal studies should be completed to 
confirm these findings. Furthermore, we did not have the gold standard for fitness, VO2 max, 
measured and instead CRF was calculated from an equation derived by (Jurca et al., 2005). 
Although, this measure is highly correlated with VO2 max, future studies interested in race and 
fitness should consider measuring VO2 max directly from at least a subset of participants to better 








4.6 FIGURES AND TABLES 
Table 4.1 Cardiovascular measures by Race (unadjusted) 
    Black White   P VALUE 
Avg. SBP 
(n) 154 589     
(mean) 122.00 115.80   <.0001 
Avg. DBP 
(n) 142 572     
(mean) 74.42 71.84   <.0001 
Fasting Glucose (mg/dL) 
(n) 150 558     
(mean) 95.36 94.85   <.0001 
            
Fasting Insulin (uIU/mL) 
(n) 135 544     
(mean) 13.1 11.01   0.0009 
(median) 11 10   0.03* 
Fasting Triglycerides 
(mg/dL) 
(n) 150 588     
(mean) 91.22 107.62   0.0066 
(median) 77 89.00   0.0004* 
Fasting HDL (mg/dL) 
(n) 150 588     
(mean) 54.86 54.18   0.6299 
Fasting Cholesterol 
(mg/dL) 
(n) 150 588     
(mean) 191.68 195   0.271 
Waist Circumference 
(cm) 
(n) 154 592     
(mean) 66.44 71.94   0.035 
median 68.26 80.01   0.26* 
Body Mass Index (kg/m2) 
(n) 154 593     
(mean) 29.15 26.40   <.0001 
Height (in) 
(n) 154 593     
(mean) 67.06 67.51   0.19 
 
Potential mediators      
CMR score (n) 135 538     
(mean) 0.19 0.00   0.0009 
CRF (n) 123 504     
(mean) -0.41 0.09   <.0001 


































-0.18 -0.20 -0.28 -0.14 -0.38 -0.34 -0.32 
<.0001 <.0001 <.0001 0.0008 <.0001 <.0001 <.0001 
CMR 
score 
-0.05 0.00 -0.10 -0.07 -0.13 -0.14 -0.12 
0.176 0.973 0.014 0.059 0.001 0.001 0.003 
Prob > |r| under H0: Partial Rho=0 
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Table 4.3 Linear regression models for Brain health measure by Race 
Brain Health Measure 
  Fully adjusted model Fully adjusted model + poor CRF Fully adjusted model + CMR 
  B 95% CI B 95% CI 
% change in 
B for Black 
race 
B 95% CI 
% change 




Black -0.4*** (-0.56, -0.25) -0.40*** (-0.57, -0.22) 2.40% -0.37*** (-0.54, -0.20) 7.60% 
Mediator     -0.03 (-0.12, 0.07)   -0.01 (-0.12, 0.10)   
Adj R2   0.42   0.41     0.42   
  Black -0.35***  (-0.47, -0.23) -0.32*** (-0.45, -0.19) 8.57% -0.37*** (-0.50, -0.24) -5.71% 
Entorhinal Cortex 
vol, cm3 Mediator     
-0.02 (-0.09, 0.06)   -0.01 (-0.09, 0.08)   
  Adj R2    0.37   0.39     0.38   
Cortical Surface area 
cm2 
Black -42.16** (-67.29, -17.03)  -35.64* (-62.85, -8.43) 15.50% -36.68** (-63.91, -9.45) 13.00% 
Mediator     -9.12 (-24.19, 5.95)   -14.45 (-32.24, 3.35)   
Adj R2   0.56   0.57     0.57   
Mean Cortical 
Thickness, mm 
Black -0.03*** (-0.05, -0.01) -0.04*** (-0.06, -0.02) -17.60% -0.03*** (-0.06, -0.01) -1.00% 
Mediator     0.003 (-0.01, 0.02)   -0.003 (-0.02, 0.01)   
Adj R2   0.15   0.14     0.14   
Cortex Vol, cm3 
Black -21.17*** (-27.67, -14.68) -21.28*** (-28.31, -14.25) -0.50% -19.93*** (-26.88, -12.98) 5.90% 
Mediator     -1.48 (-5.38, 2.41)   -3.75 (-8.30, 0.79)   
Adj R2   0.68   0.69     0.69   
Gray Matter Vol, cm3 
Black -24.71*** (-32.70, -16.72) -23.67*** (-32.39, -14.94) 4.20% -22.60*** (-31.18, -14.02) 8.50% 
Mediator     -3.10 (-7.94, 1.73)    -5.45 (-11.06, 0.15)   
Adj R2   0.73   0.73     0.74   
* p<0.05, **p<0.01, ***p<0.001 
Models are adjusted for study, ICV if volume or surface area measure is outcome, sex, age, years of schooling, family income, and current smoking. 
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Table 4.4 Test for interaction between race and potential mediator with the brain health markers 
Brain Health Measure 
Potential mediator 
 CRF CMR  
Hippocampal Vol, cm3 2.08 (0.15) 0.81 (0.37) 
Entorhinal Cortex Vol, cm3 0.06 (0.81) 0.10 (0.75) 
Cortical Surface area cm2 0.05 (0.82) 0.01 (0.92) 
Cortical Thickness, mm 0.38 (0.54) 0.06 (0.81) 
Cortex Vol, cm3 0.33 (0.57) 0.07 (0.80) 
Gray Matter Vol, cm3 0.07 (0.79) 0.004 (0.95) 
   
F-test and (p-value) reported. 
Model adjusted for study, ICV if volume or surface area is outcome, age, sex, years of schooling, 




Figure 4.1 Mediation results for Hippocampal volume 
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Figure 4.3 Mediation Results for Cortex Volume 
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Figure 4.4 Mediation Results for Grey Matter Volume 
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Table 4.5 Racial Difference in Brain Health converted to Difference in Aging (years) 
Brain Health Measure 
fully adjusted model 
B for direct effect of 
black race 
p-value
B for age in 





years of aging 
Hippocampus Vol, cm3 -0.38 <.0001 -0.014 0.0079 26.51 
Cortical Surface area cm2 -32.55 0.0264 -4.34 <.0001 7.51 
Cortex Vol, cm3 -19.86 <.0001 -1.77 <.0001 11.25 
Gray Matter Vol, cm3 -22.30 <.0001 -2.29 <.0001 9.75 




5.1 MAJOR FINDINGS 
Contemporary evidence suggests that blacks are at greater risk of cerebral small vessel disease and 
brain related sequelae (stroke, dementia, and vascular cognitive impairment). However, current 
work attempting to identify potential sources of racial health disparities in cerebrovascular and 
brain health are limited. This dissertation aimed to improve our understanding of racial disparities 
in brain health outcomes through three complementary studies. The first explored existing 
literature investigating race and markers of brain health, pointed to gaps in knowledge, and 
suggested directions of future research. The second examined whether there are racial differences 
in brain health in a midlife population. Finally, the third assessed whether cardiorespiratory fitness 
and cardiometabolic risk mediate the relationship between race and brain health.  
The literature review presented in chapter two of this dissertation highlighted gaps in our 
understanding of race and brain health. Based on the 33 publications included in the review, blacks 
appear to be at a greater risk for developing white matter hyperintensities. However, relationships 
between race with other markers of brain health remain unclear. In this review we identified major 
limitations in the current research. These include: 1) a lack of representation by younger age groups 
(specifically <65 years old), 2) limited geographic representation, 3) many publications originating 
from only a few study samples, and 4) the lack of reporting diverse markers for brain health (most 
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publications only report white matter hyperintensities). These limitations may lead to major biases 
that have limited our understanding of the pervasiveness of brain health disparities across the 
lifespan. In response to these gaps in knowledge, we set out to examine race and brain health in a 
middle-aged population and test potential mediators of this relationship.  
The results from our investigation of racial differences in brain health among a middle-
aged population are presented in chapter three. We found that blacks and whites differ in almost 
every marker of brain health except for global cerebral blood flow. Adjustment for demographics 
and socioeconomic variables attenuated relationships with race and both cortical white matter 
volume and amygdala volume. After adjustment for demographics and socioeconomic variables, 
blacks exhibited significantly lower gray matter volume, smaller hippocampus, less cortical 
surface area, and a thinner cerebral cortex than whites (all p’s<0.05). The magnitude of the effect 
of race on brain health was similar but somewhat smaller among females compared to males. There 
remained a significant and unexplained (by demographics and SES variables) effect of race on 
hippocampal volume, cortical surface area, mean cortical thickness, cortex volume, and gray 
matter volume equivalent to: 29.04, 9.47, 10.66, 9.20 and 13.96 years of aging, respectively.  
Finally, the results of the mediation analysis indicated that CRF and CMR partially 
mediated the association of race with cortical surface area, cortex volume and gray matter volume. 
The percent mediation for cortical surface area and gray matter volume was 22.79% and 5.98%, 
respectively. Additionally, we found that independent of CRF, there was an indirect effect of CMR 
on cortical surface area and gray matter volume. No indirect effects of CRF independent of CMR 
were found. There remained a significant direct and unexplained effect of race on hippocampal 
volume, cortical surface area, cortex volume, mean cortical thickness, and gray matter volume 
equivalent to 26.51, 7.51, 11.25, and 9.75 respectively. These are considered large and clinically 
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relevant differences for a middle-aged population, and future studies should investigate other 
potential mediators for these relationships. Additionally, longitudinal studies will be invaluable in 
establishing these relationships overtime and determining whether these differences are due to 
developmental causes, differences in susceptibility, or differences in exposure to risk factors for 
detrimental brain changes.  
In sum, race differences in brain health are evident in midlife. CRF and CMR factors may 
partly explain some of the racial differences in brain health and should be investigated further as 
potential targets for intervention. These results have implications for understanding the pathways 
by which race may impact brain health prior to the onset of stroke and other clinical outcomes later 
in life.  
5.2 PUBLIC HEALTH SIGNIFICANCE 
Racial differences in stroke and dementia are evident but the reasons behind these disparities 
remain poorly understood (F Gottesman et al., 2015; Husaini et al., 2003; Mozaffarian et al., 2015). 
If these trends continue unabated, the public health burden of disparities in dementia and stroke 
will increase as the population becomes older and more ethnically and racially diverse (Ortman et 
al., 2014; Pantoni, 2010). This dissertation is a significant work from a public health perspective 
for three main reasons. First, they illustrate that disparities in brain health exist in an otherwise 
healthy midlife population. Second, we investigated whether known risk factors for brain health 
decline contribute to this disparity. Third, this serves as a call to action for scientists, public health 
researchers and clinicians to investigate these disparities further. Our findings suggest that efforts 
to preserve brain health should begin before midlife, because by midlife racial differences in brain 
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health are already apparent. Research efforts should work to prevent further decline, promote 
preservation, and delay or prevent dementia and stroke events. Moreover, we need to better 
understand when these disparities begin, how they progress, and what factors confer resilience and 
risk.   
5.3 FUTURE DIRECTIONS 
The cumulative findings from this dissertation illuminates the need for future work. Many 
questions remain: Are these findings generalizable to other populations? When do these disparities 
begin? What other factors contribute to these disparities? What can we do to improve outcomes 
and prevent decline? In order to better understand these disparities, future researchers should 
consider adopting 1) a life course approach, starting during early life development, 2) a more 
complete understanding of exposure and race interactions 3) the use of multimodal neuroimaging 
paired with cognitive evaluation. Each of these three suggestions will be discussed below.  
First, to improve our understanding of these disparities future researchers should adopt a 
life course approach. A life course approach to race and brain health research would allow 
researchers to observe changes in brain health overtime and determine when disparities begin. A 
life course approach would also assist with the investigation of potential pathways, establish causal 
links, and reduce survival bias. Here we found that there were differences in brain health markers 
that were independent of many factors thought to perpetuate the disparities in stroke and dementia 
risk (blood pressure, smoking, fitness, metabolic factors, etc.). Particularly, we found differences 
in hippocampal volume that were not explained by the factors we examined here. As many of these 
volumes are known to decline with age, these findings may suggest that blacks are experiencing 
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advanced brain aging. This advanced brain aging may be due to more rapid declines in brain 
volume with aging, a similar rate in declines but declines starting at an earlier age, or less volume 
achieved during development. Upon further investigation, it appears that the race differences in 
hippocampal volume were higher at younger ages than at older ages, whereby declining volumes 
in the white population lead to a smaller difference between the two groups (P-value for interaction 
of age * race (p=0.057) in fully adjusted model) (figure 3.i.). Hippocampal volumes among the 
blacks alone appear to be maintained and the decline in hippocampal volume with aging observed 
in the whites is not observed in the blacks. Since this study is cross-sectional, it is not possible for 
us to determine if the rate of change in brain volumes over-time is the same or different between 
the two groups. We suspect that even in this middle-aged population we are observing survival 
bias in the black sample. This bias gives the appearance that the gap is closing, when really, studies 
are not including those persons who are most vulnerable to these brain changes at older ages. We 
know that minority populations are more likely to suffer from comorbidities that may lead to 
exclusion from MRI studies and have a higher risk of mortality from stroke especially at ages 
before 65. This may bias the findings even in our middle-aged sample. Future studies should 
examine younger populations and follow individuals over time to determine whether they are 
experiencing more rapid brain aging. Additionally, studies of early development would nicely 
complement our understanding of these processes by exposing factors that may drive these 
disparities later in life. Studies or early life would also help us to understand whether differences 
in brain volumes are due to differences in development or an increased rate of decline later in life.  
Second, determining what factors contribute to differences in brain health is important to 
understanding the disease etiology and determining the best ways to help prevent the progression 
and decrease racial disparities in brain health. Identification of these factors is just the first step; 
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implementation of interventions will require a more complete understanding of the barriers and 
potential risk factor interactions with race. Here we found that fitness, cardiometabolic risk, and 
socioeconomic factors (such as education and income) attenuated the magnitude of the relationship 
between race and many markers of brain health. These findings offer insights into possible targets 
for intervention. Improving education and reducing cardiometabolic risk could be key factors in 
reducing health disparities. The challenge is developing interventions that are accessible, 
generalizable and sustainable. Also, we need to be careful in designing interventions that will 
reduce health disparities and not perpetuate them. Interventions could reduce disparities either by 
primarily targeting minority groups or choosing interventions that may have an added benefit for 
blacks over whites. For example, improving fitness has been acknowledged as a way to prevent 
decline and increase brain volumes. Although CRF was not an independent mediator of race and 
brain health in this cross-sectional analysis, we found a non-significant trend indicating a possible 
interaction between race and CRF with hippocampal volume (p=0.15). This suggests that the effect 
of poor CRF may be worse for blacks as compared to whites. It is possible that exercise 
interventions may have an added benefit among those who are black and could help reduce racial 
disparities. Future studies should examine the potential of exercise interventions to reduce racial 
disparities in brain health. Beyond examining these factors, future researchers need to ensure that 
they are taking a multifaceted approach to understanding these health disparities. Race and disease 
relationships are unique to the human population. Race is an abstract and socially constructed 
concept. Race is interwoven with many different aspects of life, including: culture, diet, beliefs, 
behaviors, social and societal relationships. These complex interactions between race and many 
aspects of life can easily introduce bias. Studies need to be carefully designed to measure or control 
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for as many of these biases as possible. Future work examining these relationships requires a 
holistic approach where the complexity of race is not ignored.  
Finally, this dissertation has focused mainly on differences in brain structure, with the 
exception of CBF, in an effort to understand racial disparities in brain health. However, the role of 
cognition and brain function will be key to identifying the mechanisms by which these physical 
differences in brain structure may lead to an increase in risk of dementia. Future research in this 
area needs to consider not only brain structure, but bridge both structure and function to fully 
understand brain health resilience and the risk for detrimental brain changes in this population. For 
example, we observed differences in brain volumes but not global CBF. This finding was 
somewhat unexpected, as many argue that changes to CBF may contribute to atrophy. In order to 
better understand the implications of these findings, longitudinal data are needed, along with 
measures of cognitive performance. Here it is impossible to tell whether the preservation of CBF 
may help to compensate for the loss of tissue volume, or if volume loss precedes declines in CBF. 
Furthermore, a decline in CBF may be more detrimental to a person who has already experienced 
volume loss (e.g. if you have fewer neurons and all of a sudden you are unable to provide enough 
nutrients to the neurons you have you will be unable to perform the task). Understanding these 
relationships between structure, function, and performance may help to uncover targets for 
intervention.  
 In conclusion, future research would benefit from a life course approach that examines 
complex interactions with race and integrates multimodal neuroimaging paired with cognitive 
assessment. An example of conceptual framework that integrates the above points is given in figure 
5-a. Cross-disciplinary work is required in order to fully understand exposures, potential barriers, 




Figure 5.1 Framework for Future Research 
5.4 FUTURE CHALLENGES 
Advancements in neuroimaging have allowed us to not only visualize brain tissue, but to explore 
relationships between brain tissue and the vasculature that feeds it. Small penetrating arteries of 
the white matter and basal ganglia are hard to visualize with most non-invasive techniques such as 
CT and MRI. However, with ultra-high field time-of-flight MR angiography, we can now begin to 
characterize these penetrating small arteries in vivo. Small vessels usually manifest as thin, smooth 
and relatively straight vasculature with moderate branching. As mentioned in a prior review 
(Jorgensen, 2018), in disease states these penetrating vessels may be recruited as collateral 
pathways and greatly increase in number, with a more tortuous and aggressively branching pattern, 
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and are prone to hemorrhage. Time-of-flight MR angiography can be used to visualize small 
arteries as thin thread-like areas of flow-related contrast. Using this technique, features of 
cerebrovascular disease, such as reduced vessel number and increases in tortuosity, can be 
examined. These measures could then be evaluated as potential contributors to disparities in brain 
health. However, there are no standard approaches to processing these images. This lack of a 
standard methodology is possibly the greatest challenge when using this type of data. But, it also 
offers an excellent opportunity for innovation and creation of both an optimal segmentation and 
quantification method.  
Before vessel characteristics can be examined, the vessels need to be extracted from the 
surrounding brain tissue, a process termed “segmentation”. There are several ways to segment 
cerebral vasculature. The current “gold standard” method for segmentation would be hand tracing. 
Whereby trained individuals trace the structure of the vasculature in a MRI visualization software 
(like HOROS). Typically, this would be done in triplicate and the results of each tracing compared. 
This methodology is limited and often not an optimal choice for segmentation. Hand tracing is 
time consuming, requires the tracer to have focus, and the quality and consistency of tracings can 
be dependent on many extraneous factors. Some of these factors include, the resolution and quality 
of the image, amount of light in the room, the tracer’s vision, and the amount of coffee the tracer 
had that day. All of these factors can be minimized or controlled, but the process of hand tracing 
these vessels is imperfect and unrealistic on a large scale. Automated and semi-automated 
segmentation show promising results. Several programs exist that can segment vessels in a semi-
automated fashion. HOROS and 3D Slicer are two examples of such programs. HOROS is 
relatively easy to learn and offers a fast segmentation based on either thresholding and/or growing 
algorithms. Unfortunately, the HOROS segmentation includes vessels outside of the brain which 
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will need to be removed later. 3D slicer offers similar algorithms and does not include vessels 
outside of the brain. But, 3D slicer is bulky, not intuitive, and time intensive. The key issue with 
either software is the segmentation product is difficult to use for quantification purposes. A final 
approach to segmentation relies on collaboration with computer scientists and neuroimaging 
specialists.  A key advantage to working with time of flight images is that the vasculature is so 
much whiter than the surrounding brain tissue. This dramatic difference in intensity can be used 
as an easy way to remove nonvascular tissue. Using a bimodal distribution of voxel intensity, a 
threshold is set to determine the probability that each voxel was either part of vascular tissue or 
not. This does an excellent job for an initial segmentation; however, special masks are needed to 
remove non-cerebral vasculature while preserving the carotids.  
After the segmentation step comes quantification. There is no current standard for 
quantification. But, features of vasculature, including reduced arterial vessel number and increased 
arterial tortuosity, have been positively associated with aging (Bullitt et al., 2010) and inversely 
associated with exercise (Bullitt et al., 2009) in healthy individuals. These findings are consistent 
with previous findings from postmortem studies of small vessel disease where small vessels appear 
to greatly increase in number, with a more tortuous and aggressively branching pattern in brains 
with cerebral small vessel disease compared to those without (Fazekas et al., 1993)(see (Jorgensen, 
2018) for a review of pathologic correlates). However, the differentiation of small arteries from 
small veins is challenging in postmortem examination (Black, Gao, & Bilbao, 2009; Brown, 2010; 
Brown & Thore, 2011; Fazekas et al., 1993; Moody, Brown, Challa, & Anderson, 1995; Moody 
et al., 2004). Therefore, more studies of in vivo vascular characteristics are needed and could 
provide valuable information about arteriole vascular characteristics and pathologic responses to 
risk factors. In future studies quantifying vasculature, is important to keep in mind what that we 
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are attempting to capture a physiologic process and need to use measures that reflect this process. 
The methods used to quantify vessels should reflect two things: 1) features of the underlying 
pathophysiology and 2) an understanding of the strengths and limitations of the segmentation 
product. Optimizing these two points should result in the best and most physiologic variables for 
both analysis and interpretation of the findings.   
 In conclusion, there is ample opportunity to develop techniques to quantify cerebral 
vasculature. Multidisciplinary collaboration will be required in the development of such 
techniques. In the end, development of such methods will help improve our understanding of the 
inter-relationships between the vasculature and the neurons. We hope that a better understanding 
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